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Abstract 
Determining the Role of Trib3 in Neuronal Apoptosis 
Neela Zareen 
Naturally occurring apoptosis in the developing nervous system is an important event for the 
proper shaping of the system, for eliminating precursor cells with mutations and for curbing the 
population of post-mitotic neurons so that appropriate target innervation can take place.  In the 
latter case, neurons are usually subjected to a competition for a limited supply of target-derived 
growth factor.  A classic example includes neurons of the superior cervical ganglia that compete 
for nerve growth factor (NGF).  Cell death arising from lack of NGF stimulation is a topic of 
intense research and remains enigmatic.  Pro-apoptotic molecules that have been characterized so 
far are partially responsible for inducing death and furthermore, it is not fully understood how 
the homeostatic balance of the neuron is disrupted by NGF deprivation.  In this thesis, a novel 
neuronal pro-apoptotic protein Trib3 is defined.  It is shown to be required for developmental 
neuron death and to employ a cellular mechanism involving Akt and its substrates, the FoxO 
transcription factors.  It is also shown that Trib3 is transcriptionally regulated by the FoxO, JNK 
and apoptotic cell-cycle pathways.  The data further demonstrate that Trib3 functions in a feed-
forward loop with the FoxOs and deactivates Akt in a self-propelled pathway that amplifies the 
apoptotic cascade resulting from NGF deprivation.  Moreover, Trib3 is found to be induced and 
necessary for neuron death in cellular models of Alzheimer’s and Parkinson’s diseases.  The 
latter preliminary findings have encouraged other researchers to begin exploring Trib3’s 
mechanism and regulation in neurodegenerative disease models; this will advance our 
knowledge and understanding of the cellular processes of neuron death and may lead to 
development of novel therapeutic targets. 
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Background and Introduction 
Developmental Cell Death 
Cell proliferation and cell death are two very important events during animal 
development.  While it is readily discernible why cell proliferation is necessary as the organism 
develops from a single fertilized egg, the role of cell death is counterintuitive.  A small 
percentage of dying cells may be expected as a result of epigenetic or developmental aberration; 
however, the observed death of a massive number of cells, especially in the nervous system, 
required further explanation, prompting many researchers to investigate this phenomenon.  In 
earlier times, cell death was perceived to be a passive phenomenon.  Then a number of elegant 
studies, using RNA and protein syntheses blocking drugs, revealed that de novo expression of 
certain genes is required for this event [1].  This type of death is now known as programmed cell 
death or PCD.  The classic example of PCD is apoptosis; a process that is characterized by 
specific biochemical and morphological features, such as a decrease in mitochondrial integrity 
and membrane potential, exposure of the phospho-lipid phsophatidylserine to the outer side of 
the plasma membrane (it is normally kept in the cytoplasmic side of the membrane by the 
enzyme flippase), endonuclease degradation of DNA and chromatin condensation, and shrinking 
of the cells to form apoptotic bodies that are removed by phagocytic macrophages [2].  This is 
very distinct from necrosis, where the cells swell and burst, releasing their content into the 
environment and adversely affecting neighboring cells via inflammation [2].  Other forms of 
PCD include autophagic cell death that is characterized by autophagosomes, which are double-
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membrane vesicles containing cytoplasmic organelles or degenerating cytosol that fuse with 
lysosomes for subsequent degradation [2-4].  The newly emerging necroptosis is a form of 
programmed necrosis that is induced by stimulating death receptors and that has its own unique 
signaling pathway [5].  Since the focus of this thesis is confined to the process of apoptosis, 
henceforth any mention of PCD will refer solely to this particular form of cell death. 
The regression of massive number of cells is now acknowledged to be an integral part of 
the normal developmental process.  Whereas cell division is necessary for accumulation of 
building blocks for various organs and organ systems, cell death is crucial for shaping and 
sculpting of various organs and for tissue patterning.  This is often referred to as morphogenetic 
cell death  [6].  Examples of such events include: formation of fingers and toes, invagination of 
the epithelia as in the formation of the neural tube and evagination as in the formation of the 
optic vesicle and fusing of structures to form the palate.  Furthermore, apoptosis is effective in 
deleting structures that are no longer needed [6].  During amphibian development, the tadpole 
loses its tail and intestine on its way to becoming an adult.  In humans, males initially harbor 
mammary cells but later lose them due to testosterone exposure [6].  Apoptosis is also useful for 
quality control, which involves the elimination of cells that may acquire errors after 
differentiation or other harmful characteristics.  An example of this is the removal of 
lymphocytes that produce self-reactive receptors [6].  Molecules such as BMPs, Wnts, Shh, 
FGFs and Notch regulate differentiation at various stages and are also responsible for regulating 
early PCD [7].  For example, in Drosophila wing disc, disruption of Dpp and Wg gradients 
causes discontinuities within the smooth gradients that are then corrected by triggering PCD via 
both cell-autonomous and cell non-autonomous JNK pathway, removing the disrupting cells [7].  
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Also in Drosophila, borders between populations of different cell types are at risk for signaling 
conflict and ambiguity in identity and PCD is used to eliminate cells to sharpen and refine 
borders of segments.  Hox proteins function downstream of morphogens and have been shown to 
regulate PCD in segment borders of Drosophila and Xenopus [7].   
Though apoptosis is apparent in all organ systems during development, this phenomenon 
is quite pronounced in shaping of the nervous system [8].  During the formation of the nervous 
system, cells undergo a series of steps, which include induction, proliferation, migration, 
restriction and determination, axonal path-finding and synapse formation [9].  PCD during early 
neural development within proliferating neural precursor cells or newly formed postmitotic cells 
is important for normal development of the CNS and PNS and this is distinct from late stage 
PCD that is related to axon guidance and limitations in trophic factor availability [9, 10].  A 
primary function of early death is curbing precursor cell populations and affecting the size and 
morphology of the resulting neuronal structures [9].  In the Drosophila embryo, the first PCD 
occurs within the neural population in the head region at stage 11 [7].  In vertebrates, such as 
Xenopus, apoptosis is observed within the anterior regions of the neuroectoderm at late 
gastrulation and in zebrafish, first patterned PCD is within neural cells and occurs at 12 hours 
after fertilization [7].  In higher vertebrates, the quantity of neuron loss ranges from 15 percent of 
the initial neuron population of the auditory relay nuclei to about 85 percent in the 
mesencephalic nucleus of the trigeminal nerve of the avian brain [9].      In chicks, the first sign 
of PCD is seen in the anterior neural plate, which becomes the brain shortly after gastrulation; 
PCD continues on in the dorsal plate (neural crest cells) and floor plate (glia) cells [7].  In mice, 
apoptosis is evident during gastrulation starting at about E6.5 [7].  Virtually all neuron and glial 
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populations of the spinal cord, sensory ganglia, autonomic ganglia, the retina, brainstem, 
thalamus, cerebellum and cortex undergo PCD [9]. 
  Any interruption in the apoptotic process can have dire consequences.  Mutant mice 
deficient in proper regulatory mechanisms for apoptosis exhibit morphological deformities in the 
CNS.  For example, in mice null for Apaf-1, a factor necessary for caspase-3 activation, none of 
the homozygous embryos survive beyond E16.5 [11].  They develop severe deformities in 
craniofacial structure, such as rostral exencephaly, an absence of skull vault and facial midline 
and palate cleft; this was also accompanied by interdigital webbing in their paws [11].  
Moreover, knockout of caspase-3, the protein necessary for the execution of the final stages of 
apoptosis also results in gross abnormalities in brain formation in mice, where the brain matter 
simply protrudes out of the skull [12].   In Xenopus embryos, overexpression of the anti-
apoptotic protein Bcl-2 prolongs neurogenesis and delays axonogenesis [7]. 
Late stage PCD functions in error correction, selective removal of neurons that have 
either migrated to an ectopic position, have axons going astray during path-finding, or have 
innervated the wrong target [9, 13].  Because synaptic connections must be specific, especially 
where spatial topographic mapping must be precise, the nervous system depends on PCD to fine-
tune the connectivity.   The discovery of the first neurotrophin, nerve growth factor (NGF) by 
Rita Levi-Montalcini aided in formulating the neurotrophic hypothesis [13].  Originally the 
hypothesis stated that neurons are produced in excess and must compete for a limited supply of 
trophic support to innervate their targets, providing sufficient target innervation while those that 
lose this competition are eliminated by PCD [13, 14].  Now the hypothesis has been modified to 
include trophic support from afferent inputs and other cellular partners such as glia [9, 13, 14].  
5 
 
Trophic agents from glia and extracellular matrix and local cell-cell interactions between neurons 
and non-neuronal cells play a role in promoting the survival of developing neurons.  A 
quantitative system matching is said to be the primary role for post mitotic PCD during 
synaptogenesis in the vertebrate nervous system, where the number of surviving neurons 
correlates directly to their target tissue size (Fig. 1-1) [8, 9, 13, 14].   
 
This has been demonstrated by experiments in which complete or partial deletion of targets 
resulted in a significant increase in apoptosis of innervating neurons. Conversely experiments, 
where target availability had been increased, resulted in a dramatic increase in the number of 
surviving neurons [8, 13].  For example, a reduction of afferent input to neurons resulted in a 
significant increase in neuronal death in the cochlear nuclei of the chick and mouse and in the 
spinal motoneurons of the chick [8, 13].  In the PNS, Viktor Hamburger demonstrated the 
importance of NGF for the survival of DRG (dorsal root ganglia) neurons when he administered 
daily injections of NGF to developing chicks, which resulted in a 40% decrease in death in their 
brachial and thoracic DRG populations compared to their untreated counterparts [15].  Target or 
Target Size Controls Neuron 
Population.  Major features of 
naturally occurring neuronal death 
during development.  In most 
regions about 50 percent of the 
neurons that are initially generated 
die at about the time the population 
as a whole begins to form 
connections within its target field. 




afferent derived support is important in the CNS, as well.  The dopaminergic neurons of the 
SNpc (substantia nigra pars compacta) of the midbrain, for example, undergo naturally occurring 
cell death around the time of birth starting at E20 [16].  PCD in these neurons is biphasic in that 
it occurs again at age P12 until about P16 [16].  During the first phase of PCD, these neurons 
rely, at least in part, on a limited supply of GDNF (glial-cell-line-derived neurotrophic factor) 
from the striatum for their survival [16].  Although it has been difficult to determine the exact 
magnitude of apoptotic dopaminergic neurons during the second phase and the PCD controlling 
factors, these neurons seem to rely on their striatal target for survival during this period [16].  
Moreover, in vitro studies have revealed that embryonic mesencephalic DA (dopamine) neurons 
form an appropriate number of axons only in the presence of appropriate target tissue, and that 
the viability and differentiation of these neurons increased when they had soluble factors purified 
from the striatum in the culture medium or when they were co-cultured with the striatum [16].   
PCD in the Adult Brain 
Neurogenesis is not limited to the developing nervous system.  In humans, neurogenesis 
continues to occur in the dentate gyrus (DG) of the hippocampus, which is critical for enhancing 
neuronal plasticity in learning and memory formation and possibly holds regenerative capacity 
following injury [17, 18].  In the DG of adult rats, approximately 10,000 cells are generated daily 
and 60 to 80 percent die within 1 month after their production [19].  What is more is that many 
of these become granule cell neurons, extend axons into CA3 region and express robust LTP 
before dying, indicating that the new cells function as neurons and may be engaging in 
competition to survive just as neurons do in the developing brain [19].  Their survival is also 
dependent on the environment; hippocampal learning tasks, larger cages with more rats and 
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novel objects dramatically decrease the number of apoptotic newborn neurons [19].  
Furthermore, it appears that the molecular mechanism responsible for apoptotic death during 
development, which will be discussed shortly, is also conserved in adult neurons undergoing 
apoptosis.  For example, the BH3-multi domain protein Bax is a necessary proapoptotic factor in 
developing neurons and research has shown that adult neurodegeneration of the newly formed 
neurons in DG is greatly reduced in Bax knockout mice [20]. 
Neural loss can also result when PCD proceeds improperly due to inappropriate trophic 
factor signaling or errors in the molecular mechanisms that regulate cell survival and death, 
leading to deficits in the functional capabilities of the brain as seen in various neurodegenerative 
diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease [13].  Neurotrophins play an 
important role in maintaining survival in the adult brain.  For example, NGF maintains and 
regulates the cholinergic phenotype of basal forebrain neurons through the retrograde transport 
of the NGF/TrkA receptor complex from the cortex and hippocampus, where NGF is produced 
[21].  Furthermore, NGF has been found to protect cholinergic neurons following age-related 
atrophy and experimental surgical lesions and plays a role in improving memory in aged rodents 
(Williams 1986) [22].  Other neurotrophins such as BDNF (brain derived neurotrophic factor), 
NT-3 (neurotrophin), NT-4 and CNTF (ciliary neurotrophic factor) were found to be effective in 
rescuing axotomized facial and sciatic nerves [23].    NGF deprivation has been shown to result 
in  loss of cholinergic basal forebrain neurons in patients with Alzheimer’s disease [21, 24] and a 
recent publication reported that the level of NGF is reduced in plasma of patients with 
Huntington’s disease [25].  In AD brains, NGF levels are reduced in the basal forebrain; 
transgenic mice (AD11) with NGF neutralizing antibody exhibit progressive neurodegeneration 
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that resembles many features of AD, including redistribution of phosphorylated tau and 
accumulation of β-amyloid [21].  NGF has been used for therapeutic purposes in AD patients in 
order to reduce neuron loss; however, since NGF cannot cross the blood brain barrier, it was 
injected directly into brain parenchyma and this resulted in a rescue of the cholinergic deficit and 
decreased levels of hyperphosphorylated tau and beta amyloid, rescuing object recognition 
deficits, as well [21]. 
Neurotrophin Signaling and Neuron Survival 
Neurotrophins are a family of secreted growth factors that are important for cell 
proliferation, survival and differentiation.  The family includes nerve growth factor (NGF), 
brain-derived neurotrophic factor (BDNF), neurotophin-3 (NT3) and neurotrophin-4/5 (NT4/5) 
[26].  Their signaling is mediated via two types of receptors: the Trk family of tyrosine kinase 
receptors and the p75 receptor. The p75 receptor belongs to the tumor necrosis factor family 
[26].  NGF binds to TrkA, BDNF and NT-4/5 bind to TrkB, and NT3 binds to TrkC with high 
affinity and can also bind to TrkA and B, but with lower affinity [27].  NGF binds to TrkA, 
promoting survival and neurite outgrowth [23, 26].  The story of the p75NTR is more complex.  
Initially, it was thought that NGF binding to either TrkA or p75NTR promoted survival, but later 
the theory was modified to what is known as the “dependence receptor paradigm” when it was 
observed that unoccupied p75NTR induced apoptosis and NGF binding to p75NTR blocked this 
apoptosis [14].  However, subsequent research findings revealed that NGF acts as a pro-
apoptotic ligand of p75NTR in a variety of cells, including neurons, but promotes survival when 
bound to both TrkA and p75NTR [14, 28].  Later it was discovered that the precursor of NGF, 
proNGF, binds to the p75NTR [14].  A second receptor for proNGF is sortilin, which can bind 
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proNGF along with p75NTR and induce apoptosis (Fig. 1-2) [29].  p75NTR signaling leads to an 
increase in JNK (c-Jun N-terminal kinase), PTEN and ceramide levels and induces apoptosis 
after injury, stress or inflammation.     
 
NGF is a highly conserved protein first identified in mouse sarcoma tissues by Rita Levi-
Montalcini [30, 31].  In the PNS, NGF acts on sympathetic neurons and sensory neurons 
involved in nociception and temperature sensation; in these neurons NGF stimulates neurite 
outgrowth, hypertrophy, and synthesis of enzymes involved in neurotransmitter production, 
supporting overall survival [23, 30].  In the CNS, NGF is necessary for survival and functioning 
of cholinergic neurons in the basal forebrain [23].  NGF is first produced as proNGF molecules 
with 241 amino acids that are cleaved by convertases such as furin and convertases 1 and 2, 
resulting in formation of 13kDa mature NGF, which is also referred to as βNGF or 2.5S NGF 
[23, 32].  The mature form exists as non-covalently bound homodimer [23, 32].  NGF signaling 
takes place in two ways: locally and retrogradely from distal axons [28, 33].  A local source of 
NGF will induce axon growth whereas NGF derived from distal axons alone is sufficient to 
Death by Neurotrophins. 




retrogradely support neuronal survival [28, 33].  During local signaling, the NGF homodimer 
selectively binds to its receptor, TrkA, with a dissociation constant (kd) of 10-11 [23]. This causes 
TrkA to dimerize and autophosphorylate at several tyrosine residues in the receptor’s 
cytoplasmic domain [27].  The signal is transduced by a number of cytoplasmic molecules, 
including the GTP-binding protein Ras, signaling molecules phospholipase-Cγ, phosphatidyl 
inositol-3’ kinase and the adaptor protein Shc, which help to trigger kinase cascades that lead to 
activation of transcription factors and a variety of cellular events that ensure viability, growth, 
differentiation and injury repair [27, 34].  Ras in most cases is responsible for promoting 40 to 60 
percent of neurotrophin-dependent survival and it does so by propagating the NGF signaling via 
the PI3K/Akt and the MEK/ERK pathways [34-36].  The PI3K/Akt pathway has been shown to 
be responsible for propagating 80 percent of survival in neurons and neurite outgrowth to some 
extent; the MEK/ERK pathway is largely responsible for neurite outgrowth, but can also promote 
survival [36, 37].  PI3K can be activated by the adaptor protein Gab-1, as well [36]. 
In retrograde signaling, the NGF-TrkA complex is endocytosed and forms an organelle 
known as the signaling endosome, which is then carried to the cell body [38]. An alternate view 
is the wave theory, which states that NGF binds to TrkA at the distal axon and causes a rapid 
phosphorylation across the axonal membrane all the way to the cell body [33, 38].  The 
retrograde signaling may consist of a combination of both types and results in the activation of 
downstream effector molecules and kinases as described above [33, 38].  The developing 
sympathetic neurons from the superior cervical ganglia rely exclusively on retrograde NGF 




Akt, the Master Regulator 
Akt is the vertebrate homologue of the viral oncogene v-Akt from the transforming 
retrovirus AKT8 that was isolated from an AK mouse T-cell lymphoma [40].  The Akt, also 
known as PKB (protein kinase B), family closely resembles the protein kinase A (PKA) and 
protein kinase C (PKC) families.  There are three closely related Akt forms in mammalian cells: 
Akt1/PKBα, Akt2/PKBβ, and Akt3/PKBγ [41, 42].  Akt1 is expressed ubiquitously except for 
the kidneys, liver and spleen; Akt2 is highly expressed in muscle, intestinal and reproductive 
tissue and Akt3 is expressed the highest in the brain and testis [40].  The three Akt isoforms 
behave very similarly in that they become activated and phosphorylate their substrates with equal 
efficacy; therefore they are often perceived as being functionally redundant [40, 41].  The Akt 
molecule contains an N-terminal pleckstrin homology (PH) domain that enables Akt to associate 
with the plasma membrane, a central kinase domain and a carboxyl-terminal regulatory domain 
that contains a hydrophobic motif (HM) [40-42].   As a homologue of a viral oncogene, Akt 
activity usually leads to suppression of apoptosis and differentiation and to increased cell-cycle 
progression [40].  Various trophic factors can activate Akt, such as platelet-derived growth factor 
receptor (PDGF), insulin, epidermal growth factor (EGF), basic fibroblast growth factor, 
neurotrophins and insulin-like growth factor (IGF-I), and neurotrophins such as the likes of NGF 
and BDNF [43-46].  When growth factors bind to their respective receptors, PI3K 
(phosphoinositide-3 kinase) is activated and phosphorylates PIP2 (phophatidylinositol 3,4,5 
trisphosphate (PtdIns(3,4,5)P2) at the 3’ position on its inositol ring and converts PIP2 to PIP3 at 
the plasma membrane [41, 42, 47].  PIP3 in turn recruits Akt and 3-phosphoinositide-dpendent 
kinase 1 (PDK1) by binding to their PH domains and this is the rate limiting step of the entire 
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process [40, 42].  A class III histone deacetylase (HDAC) named SIRT1 has been shown to 
deacetylate a lysine residue in Akt’s PH domain, promoting its interaction with PIP3 and PDK1 
[48].  The final step of a multistep activation process is the phosphorylation of Akt on two 
residues: Thr308 and Ser473 [49].  The Thr308 site of Akt lies in its catalytic domain and is 
phosphorylated by PDK1, which enhances its activity over 30-fold.  The Ser473 site, lying in its 
carboxy-terminal hydrophobic motif is phosphorylated by the mTORC2 complex, which 
contains mTOR, GβL and rictor and is known as PDK2 [41, 50, 51].  The phosphorylation of 
Ser473 seems to be a prerequisite for Thr308 phosphorylation (Scheid 2002, Sarbassov 2005) 
[49, 51].  The phosphorylation of these two sites is important for Akt function in that 
phosphorylated Thr308 determines Akt activity and phosphorylated Ser473 gives Akt its 
substrate specificity [52].   Phospho-mimetic Akt mutants (T308D/S473D) exhibit constitutive 
kinase activation and alanine mutants (T308A/S473A) show little activity even after growth 
factor stimulation Akt [43].  In addition to these sites, phosphorylation at Ser124 and Thr450 
serves as the first step to full activation of Akt [43].   
The activated Akt can positively or negatively affect the functions of its substrates, alter 
their subcellular localization or modify their protein stabilities and regulate a wide variety of 
cellular processes (Fig. 1-3) [42].  Akt influences metabolism via phosphorylation of glycogen 
synthase kinase 3β (GSK3β), which regulates glycogen synthesis [42, 47]. Cell cycle progression 
and proliferation is controlled by Akt as it directly targets CDKIs p21WAF1/CIP1 and p27KIP1 and 
indirectly modulates cyclin D1 and p53 levels [40, 42].  Moreover, Akt regulates protein 
synthesis via tuberous sclerosis complexes 1 and 2 (TSC1/2), mTOR, elongation-initiation factor 




Of particular interest to this thesis work and as mentioned earlier is Akt’s ability to 
suppress apoptosis and promote cell survival.  The PI3K/Akt pathway has been found to be 
sufficient and sometimes necessary for neuron survival under various stressful conditions [53].  
In experiments where activated forms of Akt were constitutively expressed in sympathetic 
neurons, they survived even when NGF was removed [54].  Furthermore, in neurodegenerative 
diseases, a decrease in Akt phosphorylation and activation has been linked to neuron death [55].  
Akt accomplishes this by modulating the behavior and levels of various apoptotic and anti-
apoptotic factors in the cell, such as BAD, forkhead box O transcription factors (FoxOs), Bim, 
apoptosis signal-regulating kinase 1 (Ask 1), caspase 9, FasL, inhibitor of nuclear factor-κB 
kinase (IKK-NFκB), etc [43, 56].  BAD for example is a proapoptotic Bcl-2 family member and 
BAD acts by sequestering Bcl-xL, a pro-survival Bcl-2 protein, and indirectly helps to release 
cytochrome c from mitochondria [40, 57].  Akt blocks the activity of BAD by phosphorylating it 
at Ser136, which creates a binding motif for the chaperone molecule 14-3-3 and the interaction 
between BAD and 14-3-3 neutralizes BAD [57].  Other ways Akt can block apoptosis is by 
Figure 1-3 
Akt Effectors 
Hers et al. 2011 
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phosphorylating IAPs (inhibitor of apoptosis proteins) and enhancing their pro-survival 
activities, which include neutralization of caspases; Akt can also phosphorylate Apaf1 and 
reduce its pro-apoptotic function [40].  Furthermore, Akt blocks the activation of transcriptional 
pathways that become activated in neurons deprived of NGF and prevents these pathways from 
inducing downstream pro-apoptotic genes.  These include the JNK, cell cycle and FoxO 
pathways, which will be discussed in detail shortly etc. [40, 43, 56, 58]  
A number of factors can regulate Akt activity either positively or negatively by 
interacting directly with Akt; these include oncogenes T-cell leukemia (Tcl1) family members, 
JNK interacting protein 1 (JIP1), growth factor receptor-binding protein-10 (Grb10), Ras 
GTPase-activation protein (RasGAP), Hsp90/Cdc37 molecular chaperone complex, a tribbles 
homologue 3 (TRB3), adaptor protein containing PH domain, PTB domain and leucine-zipper 
motif (APPL), C-terminal modulator protein (CTMP), Akt phosphorylation enhancer or hook-
related protein-1 (APE), SH3 domain containing protein Src and Arg-binding protein 2γ, breast 
tumor kinase (Btk), prohibin 2(PHB2) and pleckstrin homology-like domain, family A, member 
3 (PHLDA2) [40, 43, 59].  During stress and injury or natural apoptotic death, Akt is 
antagonized in a number of ways.  For example, proNGF binding to p75NTR leads to apoptosis 
and this event occurs naturally during late stages of neurodevelopment in order to prune and fine 
tune synaptic connectivity.  Activation of p75NTR increases intracellular ceramide 
concentrations, which activates protein phosphatase 2A (PP2A) [60, 61].  Akt is a substrate of 
protein PP2A, which preferentially dephosphorylates Akt on the Thr308 site, but can also 
dephosphorylate the Ser473 site, leading to complete inactivation of Akt and deregulation of its 
downstream substrates [60].  In basal forebrain neurons, proNGF binding to p75NTR results in 
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induction of PTEN (phosphatase and tensin homolog deleted on chromosome 10), which is a 
dual lipid/protein phosphatase that dephosphorylates PIP3 and antagonizes Akt activation by 
PI3K [62].  As will be seen in this thesis, induction of the protein Trib3 also participates in 
regulation of Akt activity during neuronal cell death. 
The Molecular Mechanisms of Neuron Death 
As already mentioned, Akt regulates neuron survival by phosphorylating numerous 
substrates.  One group of such substrates, belongs to the forkhead family of transcription factors 
and includes FKHR (FoxO1a), FKHRL1 (FoxO3a) and AFX (FoxO4) [56, 58].  They are 
phosphorylated by Akt, which causes them to be bound to 14-3-3 proteins and retained in the 
cytoplasm [58].  When NGF or other survival factors are removed, Akt is inactivated and the 
FoxOs become dephosphorylated and free to translocate to the nucleus; there they can 
transactivate their target genes, such as Bim and Fas ligand that can trigger apoptosis [56, 58, 63, 
64].  FoxOs are powerful tumor suppressors; they were found to inhibit tumor growth both in 
vitro and in vivo in breast cancer, leukemia, prostate cancer and glioblastoma, although genetic 
inactivation of the FoxOs is rare [56].  Activation of FoxO3a has been show to induce the pro-
apoptotic BH3 only proteins Bim and PUMA in response to cytokine or growth factor 
deprivation [56, 58, 63, 64].   
In addition to the FoxOs, other transcriptional pathways become activated in response to 
NGF withdrawal.  This includes the cell-cycle, JNK, NF-Y and p53/p63/p73 pathways and this is 
in accordance with the observation that de novo transcription of genes is required for apoptosis to 
commence after removal of NGF [65-68].  As neural precursor cells exit cell cycle and 
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differentiate, levels of CDK4 drop significantly and remain low in the post-mitotic neuron and 
the CDK4/cyclinD1 complex is kept inactivated by CDK inhibitors, such as p16(INK4a) [69]. 
Trophic factor withdrawal results in the upregulation of Sertad1, which binds to CDK4/cyclinD1 
complex, rendering it impervious to p16 (INK4a); this ultimately results in an increases in CDK4 
activity [70, 71].  The substrates of CDK4 include Rb pocket proteins, such as Rb, p107 and 
p130, which bind to E2F transcription factors along with chromatin modifiers, such as Suv39H1 
and histone deacetylase, forming a DNA bound transcription-silencing complex [69].  The figure 
below (Fig. 1-4) shows that when CDK4 becomes activated as a result of NGF withdrawal, it 
hyperphosphorylates these pocket proteins, dissociating the complex and de-repressing E2F-
repressed genes, B- and C- mybs [69, 72].  B- and C-mybs are also transcription factors that are 
among the genes that are de-repressed following NGF withdrawal and CDK4 activation and 
these transactivate pro-apoptotic molecules, such as Bim [69, 73, 74].   
  
An additional known transcription pathway activated during NGF deprivation is the JNK 
pathway.  JNKs (c-Jun N-terminal kinases) are phosphorylated and activated in response to a 
Figure 1-4 




Greene et al. 2004 
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variety of apoptotic stimuli, including DNA damage, heat shock, ischemia-reperfusion, oxidative 
stress, axonal injury and loss of trophic support [65, 75]. It is not fully understood how the 
activation is initiated, but research findings so far indicate that a combination of TrkA receptor 
inactivation and proNGF mediated p75NTR activity can activate this pathway [65].  Rho GTPase 
family members Rac1 and Cdc42 lead to activation of mixed lineage kinases (MLKs) and they 
phosphorylate and activate mitogen-activated protein kinase kinases 4 and 7 (MKK4 and MKK7) 
[76].  These kinases in turn activate JNK, which then phosphorylates c-Jun at Ser63 and activates 
it [76].  Two scaffolding proteins, POSH (plenty of SH) and JIP (JNK interacting protein) 
interact with the above mentioned molecules to form a multi-protein complex (Kukekov 2006) 
[77].  c-Jun has also been shown to bind to the promoter regions of Bim and HRK/Dp5 and 
activate them [78, 79].  The peptidyl-prolyl isomerase Pin1 catalyzes cis-trans isomerization of 
the proline residue in phosphorylated Ser/Thr-Pro motifs in mitogen-activated protein kinase 
substrates, such as c-Jun [80].  Pin1 acts as a transcriptional coactivator as JNK phosphorylation 
of c-Jun promotes Pin1 and c-Jun interaction, enhancing c-Jun’s transcriptional activities [80].   
Yet another pathway activated during NGF deprivation involves NF-Y.  The transcription 
factor NF-Y is present at a constant level, bound to its target DNA region, an inverted CCAAT 
box (ICB), both during NGF signaling and under stress [68].  Upon NGF withdrawal, NF-Y 
requires interactions with coactivators CBP and P300 to transactivate Bim [68].  During various 
stresses, CBP and p300 can also bind to c-Jun, FoxO and Myb and enhance their transcriptional 
activities [68].   
A more recently emerging neuronal apoptotic pathway includes p53, p63 and p73 
proteins.  The tumor suppressor p53 is a transcription factor and promotes apoptosis by inducing 
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proapoptotic molecules involved in the mitochondrial intrinsic pathway, which include Puma, 
NOXA (BH3-only), Bax, Apaf-1 and Perp [66, 81].  A related protein p63 also plays a role in 
NGF deprivation-related apoptosis by inducing some of the genes controlled by p53; knocking 
out either p53 or p63 confers partial protection from NGF-deprivation in sympathetic neurons 
[81].  p73 is a pro-survival protein that partially antagonizes p53 and knocking out p73 induces 
apoptosis [66, 81]. 
The Bcl2/BH3 Proteins 
Once the necessary transcriptional pathways are activated in response to NGF 
deprivation, downstream pro-apoptotic genes are transcribed and translated, initiating the 
mitochondrial intrinsic apoptotic pathway.  Many of the pro-apoptotic genes that are induced 
belong to the Bcl2 family with conserved BH3 domains; their products are the gatekeepers and 
key players of the intrinsic pathway [82].  There are three classes: the BH3-multidomain anti-
apoptotic proteins, such as Bcl2, BclxL, Mcl-1 and A1 that inhibit mitochondrial cytochrome c 
release and apoptosis; the BH3-only pro-apoptotic Bim, DP5/Hrk, PUMA, Noxa, Bad, Bik and 
Bmf; and the BH3-multidomain Bax and Bak that cause cytochrome c release [82-87].   
Two Well-Known BH3-only Proteins Involved In Death Caused By NGF Deprivation 
DP5/HRK 
DP5 is the rodent orthologue of human Harakiri (Hrk) gene and was the first BH3-only 
protein to have been found to be upregulated in response to NGF deprivation in sympathetic 
neurons and in neuronal PC12 cells [88].  The JNK pathway is responsible for transcriptionally 
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regulating DP5 under stress and the Dp5 promoter region contains a binding site for c-Jun and 
ATF2 transcription factors [78].  DP5 is thought to neutralize Bcl2 and BclxL, allowing 
mitochondrial outer membrane permeabilization by Bax and Bak [82].  SCG neurons from Dp5 
or Bim knockdown animals are partially protected from NGF withdrawal related death and SCG 
neurons from either Dp5 or Bim knockout mice die somewhat slowly in the absence of NGF [85, 
88] . 
Bim 
BH3-only Bim mRNA levels are upregulated in response to NGF deprivation and the 
promoter region of Bim contains binding sites for transcription factors associated with the FoxO, 
JNK, apoptotic cell-cycle and NF-Y pathways [63, 64, 68, 74, 79, 89].  Three major isoforms of 
Bim protein are BimEL, BimL and BimS.   BimEL, BimL contain a region that allows them to bind 
to the LC8 (dynein light chain 1), a component of the dynein motor complex associated with the 
microtubule cytoskeleton.  BimEL is the major isoform of Bim found in sympathetic neurons, 
cerebellar granule neurons (CGNs) and dorsal root ganglion (DRG) neurons [79, 85].  
Overexpressing Bim in sympathetic neurons increased the level of cytochrome c in the 
cytoplasm and the number of pyknotic nuclei [79].  Sympathetic neurons and CGNs from Bim 
knockout mice were partially protected from apoptosis after NGF deprivation and K+ 
withdrawal, respectively [85].  The activation of the MLK/JNK/c-Jun pathway not only regulates 
Bim transcriptionally, but also modifies Bim post-translationally in that JNK phosphorylates 
BimEL and BimL at the Ser65 residue [90] and this process seems necessary in mediating 
apoptosis in response to trophic factor deprivation and that arising from p75NTR activation [91].  
Conversely, NGF inhibits Bim activity via the MEK/ERK pathway, which phosphorylates BimEL 
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and BimL, resulting in its ubiquitination and degradation [92, 93].  As noted above SCG neurons 
from Bim knockdown animals are partially protected from NGF withdrawal related death and 
SCG neurons from Bim knockout mice die somewhat slowly in the absence of NGF [85] . 
EglN3/SM20/PHD3, a Pro-apoptotic Protein that is not a Bcl2 Family Member 
The prolyl hydroxylase SM20 is closely related to C. elegans Egl9 protein, which has a role in 
inhibiting the egg laying process; in mammals, it is thought to be a mitochondrial protein, whose 
mRNA levels are upregulated in NGF-deprived SCG neurons [94].  SM20 is transcriptionally 
regulated by the JNK pathway and results in caspase-3-dependent apoptosis and appears to 
increase the level of cytochrome c in both cytoplasm and mitochondria [95, 96].  The SM20-/- 
mice displayed extra neurons in their superior cervical ganglia and underwent apoptosis at a 
slower rate with no apparent effects on their sensory neuron population [97].     
The Mitochondrial Intrinsic Pathway 
Until recently the view on how Bcl2 proteins interacted with each other to promote 
apoptosis has been as the following.  In a healthy neuron the BH3-multidomain Bax and Bak are 
retained in the cytoplasm through their interaction with the Bcl2, BclxL, Mcl-1 and A1 proteins 
[82].  Upon NGF deprivation, the BH3-only pro-apoptotic proteins are upregulated by the 
transcriptional pathways described earlier and they bind and neutralize the anti-apoptotic 
proteins, freeing Bax and Bak to translocate to the mitochondria [98].  There they form homo-
oligomers and insert into the outer membrane of the mitochondria, forming channels through 
which cytochrome c escapes into the cytoplasm [98].  This constitutes what is known as the 
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“displacement” model and is supported by a high resolution visualization of interactions between 
the BH3 fragment of Bim and BclxL (Fig. 1-5) [98].   
 Willis et al. 2005 
 
Since Bax and Bak are structurally similar to the anti-apoptotic proteins Bcl2 and BclxL, it was 
tested whether or not Bim can also bind Bax; an artificially induced helix form of Bim (aka 
Stapled Bim) was found to bind Bax in vitro [99].   Thus, a second model of “direct binding” 
emerged, which stated that the pro-apoptotic BH3-only proteins comprised both “sensitizers” and 
“activators” (Fig. 4) [98].  According to this model, the sensitizers such as Bad or Bik bound to 
Bcl2 and BclxL, thereby displacing them from Bax and Bak and the “activators” bound to Bax and 
Bak, triggering their oligomerization and mitochondrial localization [98].  Recently, Bim, 
PUMA and tBid (truncated Bid) were found to contain OMM (outer mitochondrial membrane) 
targeting sequences in their C-terminal portion, enabling them to bind to the OMM [100].  The 
C-terminal ends of these proteins were also shown to interact with extra-mitochondrial Bax and 
Figure 1-5 
Bax Activation 
Willis et al. 2005 
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to result in cytochrome c release [100]. In Bax null mice, developmental death is delayed, which 
resulted in superfluous facial motor neurons and superior cervical ganglionic sympathetic 
neurons [101].  In culture, the Bax-/- sympathetic neurons survived without NGF for up to 23 
days, displaying reduced numbers of processes and small soma [101]. 
Caspase Activation 
Regardless of the actual methods by which Bax is activated and the integrity of the OMM 
is compromised, cytochrome c release is a key event that precipitates caspase activation and 
execution of the final apoptotic steps [82, 98, 100, 102].  In the cytoplasm, cytochrome c forms a 
complex called the apoptosome by binding to Apaf-1 (C. elegans ced-4), caspase-9 and dATP, 
which then activates effector caspases [102].  Caspases are mammalian orthologs of the C. 
elegans ced-3 gene and are related to mammalian interleukin-1β-converting enzyme (ICE) [103].  
The name is a contraction of cysteine-dependent aspartate-specific protease [104].  In healthy 
neurons, they exist as inactive zymogens or proenzymes with three domains: an N-terminal 
domain, and a large and a small subunit.  Mammals have two distinct caspase subfamilies: one 
that processes proinflammatory cytokines and the other group is required for apoptosis; in the 
latter group there are initiator caspases that recruit various cofactors and lead to the activation of 
effector caspases that execute the final apoptotic response during cell death [103, 104].  Initiator 
caspase 9 contains a CARD (caspase recruitment domain), which is also present in Apaf-1 and is 
necessary for their interaction with each other [103].  The apoptosome binds about 5 to 7 
procaspase-9 molecules and this interaction possibly leads to a conformational change in the 
procaspases-9, bringing its catalytic domain closer to the apoptosome [105].  The active 
apoptosome recruites effector procaspase-3 or -7 and leads to their activation via proteolytic 
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cleavage; these effector caspases are necessary for the final execution of the apoptotic process 
[105, 106].  The importance of caspase-9 function is demonstrated by the observation that 
caspase-9-/- mice do not survive and have gross malformations of the brain [107].  In these mice, 
the deletion of caspase-9 leads to markedly reduced levels of active caspase-3 and apoptosis in 
the developing brain, resulting in the brain protruding out of the skull; the phenotypes of such 
mice were remarkably similar to caspase-3 null mice described earlier [12].   
NGF deprivation-related apoptosis is depended on the activation of caspase-2; however 
the position of this protein in the canonical caspase activation pathway is not clear and has been 
proposed to function as both an activator and an effector caspase [108, 109].  Whereas caspase-2 
knockdown protected WT sympathetic neurons from NGF deprivation-related death, caspase-2 
null neurons continued to undergo apoptosis as in the WT neurons; this was accomplished by a 
compensatory mechanism in which the caspase-9 pathway became activated [109].  Also in these 
neurons, the levels of caspase-9 and IAP inhibiting protein DIABLO are increased and knocking 
down caspape-9, DIABLO or Apaf-1 conferred protection from death [109].   These findings 
suggest that in WT sympathetic neurons, caspase-2 is dominant while the caspase-9 pathway is 
neutralized by IAPs (inhibitor of apoptosis) [109].   Caspase-2 does contain a CARD and has 
been shown to bind to the death adaptor protein RAIDD; however, it is not clear how caspase-2 
becomes activated as a result of NGF deprivation and BH3-protein activity [110].  Furthermore, 
since cytochrome c release is necessary in sympathetic neurons in order to trigger apoptosis, it is 
theorized that caspase-2 lies upstream of the mitochondrial intrinsic pathway or that it normally 
resides in the mitochondria and then escapes into the cytoplasm along with cytochrome c [109].  
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In conditions of heat-shock and ER stress, caspase-2 has been found to cleave Bid though the 
significance of this finding is not clearly understood [110]. 
Apoptosis  
Activated effector caspases, such as caspase-3, induce cell death by degrading their 
substrates, which include proteins involved in DNA metabolism, maintaining cytoskeletal 
scaffolds, cell-cycle regulation, signal transduction, etc. [111, 112].  During apoptosis, nuclear 
DNA is condensed and degraded into small fragments roughly 180bp long and multiples thereof; 
this is carried out by the endonuclease CAD (caspase activated DNAse) [111].  This commits the 
cells to death and also destroys any viruses and prevents harmful mutations from propagating 
any further inside the organism.  There is a caspase-regulated DNAse complex known as DFF 
(DNA fragmentation factor) that is composed of CAD and its inhibitor ICAD; in healthy cells, 
ICAD binds to CAD and keeps it inactive [111].  Effector caspases degrade ICAD, freeing CAD 
to engage in DNA fragmentation [111].  A protein named acinus is activated by caspase 3 and 
induces chromatin condensation.  The cytoskeleton of the apoptotic cell also undergoes drastic 
changes; the nucleus fragments, the cell body shrinks and the cell becomes detached from 
surrounding cells and basal membranes as a result of cytoskeletal protein cleavage by caspases 
[112].  Caspase-6 degrades lamins, the intermediate filament scaffold proteins of the nuclear 
envelope, causing nuclear fragmentation or pyknosis [111].  Caspase-3 cleaves and constitutively 
activates an F actin-depolymerizing enzyme called gelsolin; in some cells, actin itself is cleaved 
by effector caspases [111]. The serine/threonine kinase PAK is also cleaved by caspase-3 to 
generate a constitutively active kinase necessary for the formation of apoptotic bodies, which are 
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small membrane-bound vesicles containing condensed cytoplasmic material from fragmented 
apoptotic cells [111].   
Interestingly, effector caspases increase Cdk activity in the cell by degrading Cdk 
inhibitors.  The functions of Cdks during apoptosis are unclear, but their activity appears to be 
required for DNA condensation and cell body shrinkage, functions that are quite distinct from 
their normal tasks during mitosis [111].  Effector caspases also target enzymes responsible for 
repair and housekeeping in the neuron.  PARP (Poly (ADP-ribose) polymerase) is found in the 
nucleus, where it detects DNA nicks and catalyzes the ADP-ribosylation of histones and other 
nuclear proteins, facilitating DNA repair [111].  Caspase-3 cleaves PARP, a process necessary 
for shutting down energy expensive repair processes in the neuron after it has been committed to 
apoptosis [111].  Also as CAD produces many DNA fragments during apoptosis, it is necessary 
to deactivate PARP and its repair mechanism so that energy is conserved for proper conclusion 
of apoptosis [111].  In the absence of a sufficient energy pool to maintain ionic homeostasis, the 
cell can die quickly by default necrosis.     
Caspase substrates also include a large number of signal transduction proteins, such as 
mitogen-activated kinase kinase kinase MEKK1 and MST1 [111].  Caspase cleavage of 
MEKK1, for example, provides a positive feedback loop for signaling apoptosis because the 
caspase-cleaved kinase fragment induces caspase activation and apoptosis; similarly, cleavage of 
MST1 by caspase-3 yields a constitutive kinase that is a potent inducer of apoptosis [111].  
Caspase-3 can also cleave and inactivate the anti-apoptotic kinases Akt and c-Raf, thus 
propagating more positive apoptotic feedback loops [111].  The Bcl-2 family of anti-apoptotic 
proteins is also a substrate of effector caspases.  Upon their activation, effector caspases can 
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cleave Bcl2 and BclxL and generate fragments that resemble the proapoptotic family members 
Bax and Bak with proapoptotic activity [111].  This conversion is a feedback loop that ensures 
that all anti-apoptotic brakes are removed at the final stages of apoptosis and that it can proceed 
at an accelerated speed. 
Trib3 and the Tribbles Family 
Trib3, the subject of this thesis, was first described as neuronal putative cell death 
inducible kinase or NIPK [113].  Trib3 is the mammalian homolog of the Drosophila 
melanogaster gene, Tribbles, which acts as a negative regulator of String or Cdc25 and blocks 
mitosis in the early mesoderm [114, 115].  String is a phosphatase that induces cell cycle 
progression beyond the G2 phase by removing all cell division-inhibitory phosphates from Cdk1 
[114, 115].  Tribbles regulates Drosophila oogenesis by degrading Slbo, the fruit fly ortholog of 
the mammalian transcriptions factor C/EBP and it is thought that Tribbles does this as part of an 
E3 ligase complex [116].    String is subject to proteasomal degradation by Tribbles also during 
oogenesis so that a proper number of eggs versus nurse cells can form in the Drosophila, and trb 
mutant embryos undergo an extra cycle of cell division [117].  Wing development in flies is also 
regulated by Tribbles in that it reduces the protein levels of String and Twine (Cdc25 orthologs) 
in order to reduce the number of cell divisions in the wing imaginal disc as the wings are 
normally composed of a few large cells [118].  In summary, Tribbles regulates cell division 
during fly development through proteasomal degradation of the phosphatases String and Twine 
and the transcription factor Slbo [118]. 
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Mammalian tribbles family members are pseudokinases that function in a cell-type 
specific manner; they are encoded by three genes that are known as Trib1 (C8FW, SKIP1), Trib2 
(C5FW, SKIP2, GS3955) and Trib3, also known as NIPK in rodents and SKIP3 or SINK in 
humans. [118-122].  All three gene products are associated with human malignancies [122-127]. 
Trib1 mRNA is expressed in most human tissues, but in higher concentrations in skeletal muscle, 
thyroid gland, pancreas, peripheral blood leukocytes and bone marrow [128].  Trib2 mRNA is 
abundant in peripheral blood leukocytes while Trib3 mRNA is abundant in peripheral blood 
leukoctyes and in bone marrow [128].  The human Trib1 gene is located on chromosome 8 at 
q24.13 [118].  Trib1 protein can bind to 12-lipoxygenase (12-LOX), an enzyme that metabolizes 
arachidonic acid and may take part in other cellular functions [118].  Trib1 can also interact with 
MAPKK,  specifically the ERK activator MEK1 and JNK activators MKK4 and SEK1; these 
interactions have been shown to not only modulate MAPK activity, but also increase the levels 
of Trib1 [118, 119].  Trib1 is found in nuclei and contains a proline-rich domain at its N-terminal 
that is necessary for its nuclear localization [118].  All three Trib proteins have a septapeptide 
IL(D/L)HPW(F/L) motif that is important for their interaction with MEK1; mutating this motif 
in Trib1 abrogated its interaction with MEK1 and resulted in decreased levels of ERK 
phosphorylation, indicating that Trib1’s interaction with MEK1 is necessary for ERK 
phosphorylation [124].   Both Trib1 and 2 are found to be activated in myeloid leukemogenesis 
and Trib1 overexpression enhances ERK phosphorylation while reducing apoptosis of leukemic 
cells [124].  Human Trib2 gene is located on chromosome 2 at p24.3 and was identified in 
human osteoblasts; it is also highly upregulated in metastatic prostate cancer cells [118].  Trib2 is 
transcriptionally regulated by oncogenic Notch1 and both Trib1 and Trib2 proteins can bind 
COP1 E3 ligase and promote degradation of C/EBP-α, thereby inducing leukemia [122, 124].  In 
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malignant melanoma, Trib2 mRNA is upregulated and levels of mRNA encoding the pro-
apoptotic Bim protein are decreased; conversely, low levels of Trib2 and high levels of Bim 
mRNA are found in non-melanoma cells, suggesting an inverse relationship between the two 
molecules [123].  Additionally, Trib2 was found to promote the survival of melanoma cells by 
suppressing FoxO levels [123].  In Xenopus, Trib2 is necessary for proper cell division during 
the blastula stage and for proper expression patterns of neural crest cell markers, somite 
formation and eye development [129].  Trib2 was reported to interact with Akt in a co-
immunoprecipitation study and was able to block IGF1 (insulin-like growth factor) induced 
phosphorylation of Akt at both the Ser473 and Thr308 sites [130].   
The human Trib3 gene is located on chromosome 20 at p13-p12.2 and has a few splice 
variants [118, 131].  The human gene is organized into four exons interrupted by three introns.  
The mRNA isoforms contain alternative splice variants of the first exon termed 1A and 1B and 
the variant 1B can be further subdivided into smaller splice variants as shown in the figure below 
(Fig. 1-6).  Trib3 mRNA isoform 1A is detectable in unstressed HepG2 cells, but increases by 2 
fold and 4 fold in response to thapsigargin and arsenite treatment, toxins that induce ER stress 
[131].  Isoform 1B on the other hand is very scarce in unstressed cells, but increases by more 




    
A 918bp promoter region between -7857 to -6940 of human Trib3 was isolated and 
subjected to luciferase-based reporter assays, which revealed that treatment with thapsigargin 
and arsenite lead to about 500 to 900 fold increase in luciferase activity [131].  The region was 
found to have sequences of regulatory elements such as those found in the CHOP promoter 
(C/EBP) and Asns promoters (nutrient sensing response element or NSRE1) (Fig. 1-7), which are 
responsive to ER and arsenite stresses [131]. 
Figure 1-6 
Human Trib3 splice variants 




The Trib3 Protein 
Trib3 protein is homologous to serine/threonine kinases with a well conserved substrate-
binding domain known as the Trb domain, but itself is a pseudokinase in that it lacks key 
residues for catalytic and ATP binding domains and this has been confirmed by biochemical 
assays [125, 128, 130].  Over the years various researchers have shown that the mammalian 
Trib3 has a wide range of functions and binding partners.  
Trib3 interacts with the transcription factors ATF4 and CHOP [125, 131, 133, 134].  
CHOP belongs to the C/EBP family of transcription factors and is usually induced during DNA 
damage, extracellular and ER stress, causing cell cycle arrest and apoptosis [135].  ATF4 is a 
Figure 1-7 
Human Trib3 promoter 
Ord et al. 2005 
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member of the activating transcription factor family and often heterodimerizes with CHOP to 
also activate genes in response to ER stress, leading to apoptosis [136].  The ATF4-CHOP 
heterodimer binds to the Trib3 promoter region, inducing Trib3 mRNA levels in response to 
toxins that result in ER stress and cell death [131, 134].  On the other hand, Trib3 was found to 
inhibit their transcriptional activities in GT1-7 HepG2 cells; thus the Trib3-CHOP-ATF4 
interaction constitutes a self-regulatory network that regulates Trib3 levels during stress, leading 
to cell death [131, 134].  Trib3 is differentially regulated during stress; while it is upregulated 
and results in cell death in response to ER stress, it is downregulated by p53 during genotoxic 
stress [137].  Neuronal PC12 cells treated with tunicamycin underwent ER stress, resulting in 
Trib3 and PUMA upregulation and apoptosis, which were blocked by the addition of IGF-1 
(insulin-like growth factor) [138].  It was shown that Trib3 was necessary for PUMA 
upregulation and that this might have been via FoxO3 phosphorylation and activation that 
occurred as a result of tunicamycin induced deactivation of Akt [138].   
NF-κB signaling is affected by Trib3.  NF-κB belongs to a group of transcription factors 
that are involved in immune regulation and they do so by regulating downstream genes such as 
cytokines, chemokines, adhesion molecules and effectors [139].  NF-κB also plays critical roles 
in regulating cell death and cell survival as it transactivates genes necessary for proliferation and 
cell death.  These include Casper/c-FLIP, c-IAPs, TRAF1, TRAF2, Bfl-1/A1, BclxL, Fas ligand, 
c-myc and cyclin D1 [140].  NF-κB exists as a heterodimer consisting of a DNA-binding subunit 
p50 and a transactivator p65 [140].  The phosphorylation of p65 causes NF-κB to interact with 
transcriptional co-activator p300/CBP (CREB binding protein), which enhances the 
transcriptional competence of nuclear NF-κB [140, 141].  Trib3 has been found to bind to p65 
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and block its phosphorylation by PKA (protein kinase A), thus negatively regulating NF-κB 
dependent transcription [139].  The phosphorylation and activation of p65 generally promotes 
cell survival and Trib3 overexpression has proved to sensitize cells to TNF and TRAIL induced 
apoptosis [139]. 
Aside from playing a role in cell death in response to stress, Trib3 is also highly 
expressed in certain carcinomas including lung, esophageal and colon tumors, in acute myeloid 
leukemia and in various human gastrointestinal cancer lines [125, 126, 142, 143].  Experiments 
using PC6-3 (human prostate carcinoma) cells revealed that Trib3’s mRNA and proteins levels 
are induced in tumor cells that are starved of nutrients, such as glucose and amino acids, as it 
usually happens when tumors reach a critical mass [144].   This induction of Trib3 was 
dependent on PI3K activity as treatment with drugs that block PI3K also blocked Trib3 
upregulation [144].  Interestingly, this study showed that Trib3 induction in response to limiting 
nutrient conditions actually promoted their survival and protected the cells from starvation-
induced apoptosis thus allowing the growth of tumor cells even in less favorable environments 
[144].    
The transcriptional regulator CtIP (CtBP-interacting protein) is implicated in 
tumorigenesis and is known to interact with Rb, BRCA1 and LOM4 and has been shown to bind 
Trib3, as well [142].  Trib3 expression is also necessary for the migration and invasion of HepG2 
cells in vitro and is responsible for regulating the TGFβ-SMAD pathway [145].   Trib3 is in a 
positive feedback loop with the transcription factor SMAD3 in that Trib3 binds to it and 
facilitates its translocation to the nucleus, where SMAD3 in turn transactivates Trib3 [145]. 
SMAD3 is a target for Smurf2 (SMAD ubiquitin regulatory factor 2), which ubiquitylates and 
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degrades SMAD3; Trib3 stabilizes SMAD3 by binding Smuf2 and leading to its degradation via 
the ubiquitin-proteosomal pathway [145].   As the cells in the growing tumor experience hypoxia 
and anoxia, the resulting stressful conditions illicit responses such as the UPR (unfolded protein 
response).  CHOP, ATF4 and Trib3, factors involved in ER stress, also become activated in these 
cells [125, 146].  Experiments with human adenocarcinoma and osteosarcoma cells revealed that 
Trib3 is induced by ATF4, which then binds ATF4 and leads to its degradation; this negative 
feedback loop between ATF4 and Trib3 downregulates the stress signal and allows tumor cells to 
adapt and continue with growth [125].   In anoxic breast cancer cell lines, Trib3 is induced by 
HuR, ATF4 and NFκB pathways and may also be regulated by HIF-1α (hypoxia-inducible factor 
1), which is activated by a broad range of oxygen concentrations in order to protect cells from 
the damaging effects of oxidative stress.  [146].  A global gene expression profiling revealed that 
Trib3 is induced in ischemic preconditioning of rat retina, as well [147].  So far Trib3 is induced 
in mammalian cells subjected to various stresses and induces apoptosis or promotes survival 
depending on the circumstances and cell type.  The following paragraphs will reveal yet other 
functions of Trib3, which include regulating signal transduction and energy metabolism. 
Trib3 gene expression is high in HeLa cells, where Trib3 can bind the MAP kinases 
MEKK1 and MKK7 and enhance ERK and JNK activation at low concentrations, but not at high 
doses and conversely, MKK7 overexpression leads to increased levels of Trib3 protein [128].  
Trib3 transcripts and proteins have short half-lives, but Trib3’s interaction with MAPKKs 
stabilizes its protein level. Thus, Trib3 is able to modulate MAPKK activity by either a positive 
feedforward or negative feedback loop depending on its concentration in the cell [128].  The E3 
ligase SIAH1 (seven in absentia homolog) binds to Trib3, leading to its ubiquitination and 
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proteasomal degradation [148].  Trib3 itself associates with the E3 ligase COP1 and promotes 
degradation of ACC (acetyl-coenzyme-A carboxylase), an enzyme necessary for long fatty acid 
chain synthesis [149].  In this manner Trib3 enhances lipolysis under fasting conditions [149]. 
Transgenic mice expressing Trib3 in adipose tissue were found to be protected from diet-induced 
obesity that results from enhanced fatty acid oxidation [149].   
Aside from the MAP kinases, Trib3 also has been reported by various researchers to 
regulate the serine/threonine kinase Akt [130, 150-154].  This is of particular relevance to the 
present thesis work as will become apparent as we proceed.  A yeast-two hybrid screen revealed 
for the first time that Trib3 is a binding partner for an Akt1 mutant that lacks its N-terminal PH 
domain; this was followed by mammalian two-hybrid assays in 293T cells that showed Trib3 
interacting with  WT Akt [130].   Co-immunoprecipitation studies of proteins from HepG2 
whole-cell extracts showed endogenous Trib3-Akt interaction and exogenous flag-tagged Trib3 
coprecipitated with HA-tagged Akt1 and Akt2 [130].  Furthermore, a Trib3 splice variant lacking 
residues 239-265 (ΔTrib3) interacted only weakly with Akt [130].  It was also reported that 
Trib3 overexpression inhibited IFG1 (insulin-like growth factor) induced Akt phosphorylation at 
both Thr308 and Ser 473 residues and that although Trib3 can bind both phosphorylated and 
unphosphorylated Akt, it interacts with unphosphorylated Akt with stronger affinity [130].  
Furthermore, residues 240 to 315 of Akt1 were necessary for association with Trib3, which 
indicated that Trib3 may bind Akt and physically block the Thr308 phosphorylation site [130].  
Trib3 was found to engage Akt during insulin signaling in various non-neuronal cells [155].  
Under normal conditions, food intake results in insulin stimulated uptake of glucose in muscles 
and other tissues and inhibits hepatic glucose production.  The action of insulin on hepatocytes 
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commences as insulin binds to its receptor and phosphorylation of insulin-receptor substrate 
proteins takes place on tyrosine residues.  Eventually Akt is phosphorylated and phosphorylates 
and inhibits GSK3β, which positively regulates gluconeogenesis.  Akt also blocks FoxO1 
activation, inhibiting the transcription of gluconeogenic genes.  The end result is a reduction in 
gluconeogenesis and hepatic glucose output.  In hepatocytes that are particularly responsive to 
insulin and in HEK293 cells, Trib3 was observed to interfere with insulin signaling and glucose 
metabolism by binding to Akt and blocking its phosphorylation at both the Thr308 and Ser473 
residues [130].  In normal mice, Trib3 is induced up to 10 to 20 fold by starvation and was found 
in complexes with Akt [130].  The same research showed that Trib3 binds preferentially to the 
unphosphorylated version of Akt and that it most likely masks the Thr308 residue, physically 
preventing it from becoming phosphorylated [130].  Trib3 is also elevated in obese diabetic 
mice, where increased expression of Trib3 blocks Akt activation, leading to insulin resistance, 
hyperglycemia and non-alcoholic fatty liver disease (NAFLD) [130, 150].  In another study, it 
was determined that chronic ethanol intake resulted in insulin resistance and hyperglycemia in 
rats and that the mechanism responsible was decreased levels of phospho-Akt due to elevated 
levels of Trib3 protein in liver cell cytoplasm [151].  In utero exposure to ethanol also resulted in 
insulin-resistant diabetes in muscle cells of rat offspring [152].  Reduced levels of phospho-Akt 
were also observed in these cells and in liver cells of other rats maintained on an ethanol diet, 
accompanied by elevated levels of Trib3 and PTEN that were also hypoacetylated [152, 153].  
PTEN is a known negative regulator of Akt and deacetylation enhances its activity and this is in 
concordance with the observed decrease in Akt activity in these cells; however, it is unclear what 
the significance of Trib3 acetylation is [153].  It has been long observed that pancreatic β-cells 
die from apoptosis in female rats shortly after parturition and it is now determined that there are 
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reduced levels of phospho-Akt, and increased ATF4/CHOP-dependent stimulation of Trib3 
expression resulting from ER stress and UPR [154].  
A missense Trib3 polymorphism, with a minor allele frequency of 15%, has been 
described in which a glutamine residue is substituted by an arginine at position 84 (Q84R) [156].  
This Trib3 variant binds to the pleckstrin homology domain of Akt with high affinity, preventing 
its plasma membrane association, and overexpressing the variant decreased insulin induced 
phosphorylation and activation of Akt by approximately 22% [156].  Molecular modeling 
suggests that the RR (homozygous mutant) variant may form additional salt bridges with the PH 
domain of Akt, which may account for the higher affinity of this mutant for Akt [157].  The RR 
variant attenuated insulin-induced phosphorylation of Akt on both of its regulatory sites and 
since eNOS is a substrate of Akt, eNOS phosphorylation was reduced, as well [157].  Insulin 
stimulated production of NO and cyclic GMP that are necessary for vasodilation in cells 
expressing Trib3 Q84 in comparison with cells expressing the R84 variant, which displayed only 
a small increase [157].    Both Italian Caucasians and a Chinese population with the Q84R Trib3 
polymorphism displayed reduced insulin sensitivity and high cardiovascular risk factors, such as 
abdominal obesity, hypertriglyceridemia and thickening of the intima-media (innermost two 
layers of the arterial wall) and a predisposition toward type 2 diabetes and myocardial infarction 
at earlier age compared to individuals with the QQ genotype (WT homozygous) [158-162].   
Adding to Trib3’s repertoire of activities was the finding that it may have a role in neuron 
death.  Mayumi-Matsuda et al. used RLCS (restriction landmark cDNA scanning) and reported 
that Trib3 cDNA levels were upregulated when the PC6-3 subline of PC12 cells and developing 
sympathetic neurons were deprived of NGF for various time periods between 6 and 24 hours 
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[113].   Given Trib3’s well documented role in inhibiting Akt phosphorylation and given the 
importance of Akt in neuron survival, it is not unreasonable to contemplate what role, if any, 
Trib3 might have in neurons.  The group also reported that cortical neurons overexpress Trib3 in 
response to Ca2+ ionophores excitotoxicity [113].  Similar findings were reported by Kristiansen 
et al 2011 when they reported that Trib3 mRNA levels are up regulated in developing rat 
sympathetic neurons in response to NGF deprivation for 18 hours and that this effect is 
attenuated in the presence of MLK inhibitor CEP11004, indicating that Trib3 may be regulated 
by the MLK/JNK/cJun pathway [163].  Furthermore, Trib3 became upregulated in neuronal 
PC12 cell treated with 6OHDA (6-hydroxy dopamine), a neurotoxin that enters neurons via 
dopamine and noradrenaline reuptake transporters and selectively kills dopaminergic neurons 
and is used to induce Parkinsonism in laboratory animals [164].  The toxin is also used in 
neuronal cultures to study the molecular mechanisms of sporadic Parkinson’s disease.  SAGE 
(serial analysis of gene expression) revealed that treating neuronal PC12 cells with 100 µM 
6OHDA for 8 hours results in upregulation of Trib3 mRNA among others (c-Fos, cJun, ATF4, 
CHOP, RTP801), raising the possibility that Trib3 is involved in Parkinsonian 
neurodegeneration [164].   
The NGF-Deprivation Model 
Cell culture models are effective tools for studying death promoted by NGF deprivation.  
These models include PC12 cells (pheochromocytoma cells) and neonatal sympathetic neurons 
from the superior cervical ganglia that are dependent on NGF for survival. PC12 cells closely 
resemble sympathetic neurons in that they synthesize and store dopamine and norepinephrine 
and they respond to NGF by exiting the cell-cycle, becoming electrically excitable and producing 
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neurites at which point they are referred to as neuronal PC12 cells [165]. They are a useful 
component of the NGF-deprivation model in that they undergo apoptosis when NGF is 
withdrawn from the medium just as sympathetic neurons do in culture and in vivo during 
development [166].  Furthermore, the ease with which PC12 cells can be propagated and grown 
in abundance reduces the need for animal sacrifice and time consuming dissection for primary 
neuronal culture. Much of our current knowledge about the various molecules and pathways 
involved in neuronal apoptosis have been obtained by experiments carried out in PC12 cells by 
various researchers and then corroborated in primary sympathetic neuronal cultures [64, 74, 88, 
167].  Primary sympathetic neurons are obtained from early postnatal rat pups, a period during 
which developmental PCD of these neurons continues in vivo.  Therefore, this culture is effective 
in corroborating experimental data initially obtained from neuronal PC12 cells.  The NGF-
deprivation model is very useful in not only understanding the cell death process during 
development, but also may also provide insight about pathological neuron loss observed in 
various neurodegenerative diseases. 
Relevance of NGF Deprivation Models to Neurodegenerative Diseases 
Many of the key molecules first characterized in the NGF-deprivation model were found 
to play critical roles in mediating death in diseases, as well.  For example, aside from NGF 
deprivation, Bim transcripts and protein were shown to be upregulated in the entorhinal cortex of 
postmortem AD brains [168].  Furthermore, when cultured cortical and hippocampal neurons 
were treated with Aβ, Bim became upregulated and was found to be required for the death 
promoted by Aβ in these neurons [168].  The apoptotic cell-cycle pathway described earlier is 
also responsible for transcriptionally upregulating Bim in AD neurons and in AD culture models 
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[64, 168].  As another example, transcript levels for the BH3-only gene Dp5 were upregulated in 
CGNs (cerebellar granule neurons) in response to KCl and serum deprivation, in cortical neurons 
in response to amyloid β peptide toxicity, in axotomized retinal ganglion cells, in axotomized 
mouse motoneurons and in the spinal cords of human amyotrophic lateral sclerosis patients [169, 
170].  Finally, as has been discussed earlier, there may be a direct correlation between loss of 
NGF support and development of neurodegenerative diseases, such as Alzheimer’s disease.  
Using neuronal PC12 cells, it has been shown that NGF and TrkA signaling is necessary for 
normal processing of APP (amyloid precursor protein) and cell differentiation and survival [171-
173].  These findings have been corroborated in hippocampal neurons, a neuron population 
susceptible to amyloid β toxicity in the diseased brain [172, 173].  Thus, the NGF-deprivation 
model, comprised of neuronal PC12 cells and primary neonatal sympathetic neurons in culture, 
is a potentially useful system for investigating the possible role of Trib3 in both normal and 
pathological neuron death and answering questions regarding its mechanism and regulation. 
Rationale and Aims of this Thesis 
Though much has been uncovered regarding the molecular mechanisms by which 
neurons die from NGF deprivation, the entire process is not fully understood.  The BH3-only 
proapoptotic genes Bim, Dp5 and the prolyl hydroxylase SM20 are important for inducing death 
in this paradigm; however, they are not indispensable because their deletion affords only partial 
protection from death [85, 87, 97], indicating the existence of other pro-apoptotic molecules.  
Furthermore, the roles they play involve directly compromising the integrity of the mitochondrial 
membrane and promoting cytochrome c release, events that are many steps downstream of the 
initial stress resulting from NGF deprivation.  Therefore, it is also possible that there are 
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unidentified molecules that may be involved in processes further upstream of the apoptotic 
cascade.  Trib3 presents itself as an attractive candidate that may fit the above criteria for two 
reasons.  One, it is upregulated in NGF deprived neuronal cultures, suggesting that it might be a 
pro-apoptotic molecule; and two, because it negatively regulates Akt in non-neuronal cells, it 
may do the same in neurons, thereby regulating the apoptotic cascade many steps upstream of the 
mitochondrial intrinsic pathway and caspase activation.  Since Akt activation is of paramount 
significance for neuron survival, the activation process is regulated at multiple steps by multiple 
factors as already discussed here [43, 59]. On the other hand, developmental apoptosis that 
occurs in response to limited levels of NGF in the periphery is also crucial for proper formation 
of neuronal circuits.  Therefore, a molecular switch must exist in order to tip the closely 
regulated homeostatic balance of the neuron in favor of apoptosis.  Just as we have observed 
self-amplifying pathways that effectively divert all energy toward apoptosis and ensure its proper 
conclusion post caspase activation [111], it is possible that similar self-amplifying pathway(s) 
exist(s) that is/are responsible for rapidly amplifying the effects of a limited NGF supply, thereby 
effectively deactivating Akt and initiating neuron death.     
After the initial reports made by Mayumi-Matsuda et al., [113] no follow up research has 
been conducted to explore the significance of Trib3 mRNA upregulation in NGF deprived 
neurons; therefore, it was logical and important for me to ask what role, if any, Trib3 plays in 
neuronal apoptosis, what molecular mechanism(s) it employs and how it is regulated in neurons 
under stress.  In addition, given the observed tendency of Trib3 to interact with a wide variety of 
proteins and, at times, engage in feedback and feedforward loops, it was of interest to explore 
whether Trib3 can potentially play a key role in an amplification process that might disable Akt 
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signaling.  If Trib3 does play a role in amplifying the apoptotic signal at its onset in the NGF-
deprivation model, this would be an important insight, which may enable researchers to gain 
control over the process of apoptosis in adult neurons and to potentially decelerate or halt the 
progression of neurodegeneration.  Therefore, in addition to investigating Trib3’s role in the 
NGF-deprivation model, I briefly explored its role in the 6OHDA and amyloid β toxin models of 
pathologic neurodegeneration.   
Based on the rationale and aims discussed above, this thesis tests the following hypotheses 
regarding Trib3 and its role in neuron death caused by NGF deprivation. 
Hypotheses and Findings 
I. Trib3 is involved in inducing apoptosis in neurons deprived of NGF.  Trib3 
mRNA is upregulated in stressful conditions, such as ER stress, oxidative stress, and 
excitotoxicity and induces apoptosis [113, 133, 134].  Sympathetic neurons and PC12 
cells deprived of NGF also exhibit an increase in Trib3 mRNA levels [113].  
Therefore, it is possible that Trib3 is involved in the apoptotic process responsible for 
developmental sympathetic neuron death during development.  My experimental data 
show that Trib3 is both sufficient and necessary for death of cultured PC12 cells and 
sympathetic neurons after NGF deprivation.  
 
II. Trib3 regulates Akt phosphorylation in neurons and mediates apoptosis by 
causing Akt deactivation.  The PI3-K/Akt pathway is an important transducer of 
NGF signaling and is necessary for maintaining neuron survival [53].  Trib3 has been 
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shown to block Akt phosphorylation and activation in hepatocytes, resulting in 
disruption of insulin signaling and glucose metabolism [130].  Given the importance 
of Akt in neuron survival, it is necessary and logical to investigate whether or not 
Trib3 plays any role in regulating Akt activity in neurons.  My findings show that 
Trib3 is sufficient to lower Akt phosphorylation in neurons and that Trib3 plays a role 
in the decrease in phospho-Akt levels that occurs in NGF-deprived neurons. 
 
III. Trib3 is transcriptionally regulated by the FoxO, JNK and apoptotic cell-cycle 
pathways.  Programmed cell death resulting from NGF deprivation requires 
activation of the FoxO, JNK and the apoptotic cell-cycle pathways [64, 69].  The 
transcription factors associated with these pathways are responsible for activating 
downstream proapoptotic genes.  These include the BH3-only molecules Bim, Dp5, 
and the non-BH3 SM20 [64, 78, 96].  If Trib3 has a pro-apoptotic role in neurons, it is 
possible that it too is under the transcriptional regulation of these pathways.  My data 
show that Trib3 induction after NGF deprivation requires FoxO transcription factors.  
It also appears that JNK and apoptotic cell cycle signaling is also required. 
 
 
IV. Trib3, Akt and FoxO are linked in a self-amplifying feedback loop.  Pro-apoptotic 
FoxO activity is negatively regulated by Akt and therefore increases with NGF 
deprivation [56].  Since FoxO also regulates Trib3 expression and Trib3 inhibits Akt 
activity, NGF deprivation should trigger a self-amplifying loop that includes Akt, 
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FoxO and Trib3.  My data support such a loop and show that Trib3 is required for 



















Results and Discussion 
Introduction 
Neuronal apoptosis in the developing nervous system is important for proper shaping of 
the system’s structure and elimination of neural pre-cursor cells harboring damaging mutations 
[9].  Target-derived neurotrophic factors play a significant role during late-stage neuronal 
apoptosis in that their limited availability results in the disposal of approximately half of all post-
mitotic neural population, allowing only those neurons that match their targets to survive and 
establish functional neural connectivity [8, 9].  NGF is the quintessential neurotrophic factor that 
promotes the survival of sympathetic and a sub-population of sensory neurons in the PNS, where 
they compete for its limited availability [14, 15, 31].  A hallmark feature of the naturally 
occurring PCD resulting from this competition is the de novo transcription-dependent synthesis 
of pro-apoptotic proteins, without which the process is inhibited [1].  Neuronal apoptosis is a 
complex process that employs a variety of intracellular proteins and pathways and is not 
understood in its entirety.  RNAi knockdown and genetic knockout studies of the traditional 
BH3-only genes revealed they are important, but not indispensable in inducing apoptosis and that 
other pro-apoptotic molecules must exist [85, 87, 97].  Moreover, the molecular process via 
which a limited supply of NGF deregulates the neuron’s homeostatic balance is not understood 
well.   It is likely that the deactivation of a master regulator of cell survival, Akt, is an integral 
part of this process.  The pseudokinase Trib3 has been known to negatively affect Akt activation 
in non-neuronal cells under various stressful conditions [130, 150-154].  Therefore, because it 
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was reported that Trib3 mRNA is upregulated in the NGF-deprivation model [113], I decided to 
investigate its potential role in mediating apoptosis in NGF-starved neuronal PC12 cells and 
neonatal sympathetic neurons.  In this chapter, I present the experimental data and their possible 
significance. 
Results 
Trib3 mRNA and protein are upregulated in response to NGF deprivation.  It has been 
reported that Trib3 transcript levels are upregulated in NGF-deprived SCG neurons [113], [163]. 
I sought to confirm this in neuronal PC12 cells and SCG neurons by subjecting the cultures to 
NGF withdrawal for various time periods and found that Trib3 mRNA levels are indeed 
upregulated in both cell populations and that the extent of induction was approximately 3-7 fold 
before the first evident signs of cell death caused by NGF deprivation at about 16 hours (Fig. 2-
1A-C).  In SCG neuron cultures, Trib3 mRNA appeared to be maximally induced by as early as 
4 hours after NGF removal (Fig. 2-1C).  The experiments presented in Fig. 2-1 A and C were 
done using antibody against human NGF and therefore to rule out possibilities of any artifact 
arising from using this antibody, I repeated the NGF withdrawal in neuronal PC12 cell cultures 
where NGF was removed by repeatedly washing of the cells with NGF-free medium without the 
addition of anti-NGF antibody (Fig. 2-1 B).  In this case also, there was an appreciable induction 
of Trib3 mRNA. 
In order to determine whether the induction of Trib3 mRNA is reflected by elevation of 
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Figure 2-1:  Trib3 is induced in response to NGF deprivation. Neuronal PC12 cells (A, B) 
and SCG neurons (C) were deprived of NGF for the indicated times. Anti-NGF antibody was 
used for PC12 cells (A, D) and SCG neurons (C) and NGF was removed by repeated washing of 
PC12 cells (B) without the use of anti-NGF antibody.  Total mRNA was isolated and subjected 
to reverse transcription followed by quantitative PCR using Trib3 primers (A-C). Rat GAPDH 
and alpha-tubulin mRNA levels were used to normalize input cDNA. The data are reported as 
relative increase in mRNA levels normalized to NGF control and represent mean +/- S.E. of 
three experiments for PC12 cells (A, B) and +/- range of two experiments for SCG neurons (C). 
(D, E) Neuronal PC12 cells were deprived of NGF for 17 hours.  Whole cell lysates were 
subjected to SDS PAGE.  Error bars represent mean +/- S.E. of four experiments.  
Immunocytochemistry of SCG neuron (F) and neuronal PC12 cell (G) cultures showing Trib3 
protein upregulation after NGF deprivation.  Tuj1 immunostaining (green) for neurons and 
ToproIII staining (blue) for nuclei were done, as well.  Note absence of signal in presence of a 
Trib3 blocking peptide. *p<0.05; ¥p<0.005 vs. no NGF withdrawal (Student’s t-test).   Scale bar 
for SCG neurons = 19 µm and for PC1 2 cells = 28 µm. 








NGF deprivation, which revealed that there is an approximate doubling of the Trib3 protein 
levels (Fig. 2-1 D, E).  Immunostaining of SCG and PC12 cell cultures also indicated an increase 
in Trib3 protein expression levels after NGF withdrawal.  Expression was mainly cytoplasmic 
with some apparent nuclear staining (Fig. 2-1F, G). 
Trib3 mediates neuron death caused by NGF deprivation.  Since the discovery of Trib3 
mRNA upregulation in SCG neurons after NGF deprivation, nothing has been reported about 
what role Trib3 may actually play under these conditions.    To explore this, three independent 
shRNA constructs against rat Trib3 were generated and two of these constructs were delivered 
by either transfection or lentivirus transduction to neuronal PC12 cells and SCG neurons, 
respectively. The lentiviral constructs also expressed eGFP and proved to be nearly 100% 
efficient in infecting both neuronal PC12 cells and SCG neurons (Fig. 2-2F). The shRNA 
constructs efficiently knocked down over-expressed rat Trib3 in HEK293 cells (Fig. 2-2A, B).  
They also effectively silenced expression of endogenous Trib3 in NGF deprived sympathetic 
neurons (Fig. 2-2E).   
Initial experiments carried out with neuronal PC12 cells indicated that Trib3 knockdown 
using shTrib3#1 provides partial protection from NGF deprivation with approximately 2-fold 
more cells surviving after 24 hours (Fig. 2-3A).  Extension of these studies to sympathetic 
neurons revealed that Trib3 silencing protects both cell bodies and neurites for at least one week 
following NGF withdrawal (Fig. 2-3 B-D). Quantification of neuron survival confirmed the long-
term protective effect of Trib3 knockdown (Fig. 2-3E and F); similar results were achieved with 
shTrib3#1 and shTrib3#2, and so the data were pooled in (Fig. 2-3F). An average of about 65% 
of Trib3 deleted neurons survived after 6 days of NGF deprivation versus about 25% of NGF 
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deprived control neurons. (Fig. 2-3E, F).  A scrambled shRNA against Trib3 was used as the 
control (Fig. 2-3E) in some experiments and a shRNA against dsRed was used as the control in 
other experiments (Fig. 2-3F).  Both yielded comparable results, indicating that there were no 
non-specific effects of shRNAs or virus on neuron survival. 
The BH3-only pro-apoptotic protein Bim is induced in response to NGF deprivation and 
its deletion or silencing in sympathetic neurons and PC12 cells provides partial protection from 
NGF deprivation [74, 85]. The effects of Bim and Trib3 knockdown, either separately or 
together, were investigated.  A previously described siRNA sequence against Bim, shBim#1 that 
effectively silences endogenous rat Bim [74], was cloned into the lentiviral plasmid.  A second 
independent lentivirally-delivered shRNA that reduces endogenous rat Bim expression by 75-
80%, shBim#2, was also generated (Fig. 2-2D, E).  Silencing of both Bim and Trib3 led to only a 
modest increase in protection (Fig. 2-3A, G, H).   These data indicate that Trib3 is a necessary 
for mediating neuron death evoked by NGF deprivation and that Trib3 and Bim participate along 
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Figure 2-2: shTrib3 constructs knock down both exogenous and endogenous Trib3. (A) 
HEK293 cells were co-infected with lentiviruses expressing Trib3 and shTrib3 or control shRNA 
(sh_dsRed or scrambled shTrib3#1) constructs, and whole cell lysates were prepared three days 
later and subjected to immunoblotting for Trib3 or GFP.  (B) Quantification of relative Trib3 
protein expression under conditions described in panel (A).  Values are normalized to GFP 
expression to correct for infection efficiency and are expressed as means ± S.E. of three 
experiments.  (C) Neuronal PC12 cells were infected with lentivirus infected with either control 
(sh_dsRed) or shRNA against two different Bim for 3 days and subjected to NGF deprivation for 
16 hours.  Cells were lysed and lysates subjected to immunoblotting using antibody against Bim.  
(D) The relative protein levels were normalized against total ERK and quantified.  (E) SCG 
neuronal cultures were infected with either control or shTrib3#1 expressing lentivirus for 3 days 
followed by 8 hours of continued NGF treatment or NGF deprivation, all as indicated.   Neurons 
were fixed and immunostained using antibody against Trib3 and ToproIII nuclear staining was 
used, as well. (F) In order to assess the efficacy of lentiviral transduction, both neuronal PC12 
cells and SCG neurons were infected with shTrib3 expressing lentivirus for 3 days and then 
imaged using an epi-fluorscent microscope.  Differences from Trib3 expressing samples without 
Trib3 shRNA: *p<0.005; **p<0.05; ***p<0.0005 (Student’s t-test). Scale bar = 30 µm. 
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Figure 2-3:  Trib3 is required for neuronal apoptosis caused by NGF withdrawal.  (A) 
Neuronal PC12 cells were transfected with either control shRNA, shTrib3, shBim or 
shTrib3+shBim constructs in the pSIREN vector and NGF was either retained or removed from 
the medium 48 hours post transfection. Viable, transfected (GFP+) cells were counted at 
indicated times after NGF withdrawal. Values represent means ± S.E. (four independent 
experiments, each in triplicate or in sets of 6) and are expressed relative to cell number with NGF 
and control shRNA construct.  (B-D) Confocal images of SCG neurons infected with either 
control or shTrib3 lentivirus for 72 hours, followed by NGF deprivation for 7 days.  Note the 
presence of many neurites in cultures without NGF and infected with shTrib3. Scale bar = 16 
µm.  (E) SCG neurons were infected with the indicated lentiviruses including a different control 
shRNA (scrambled shRNA against Trib3) and an shRNA construct against Trib3, and surviving 
neurons were counted at indicated times and values are given as means ± S.E. (a single 
experiment performed in triplicate) relative to the neuron number in cultures with NGF and 
control shRNA.  (F-H) SCG neurons were infected with the indicated lentiviruses, which include 
control (sh_dsRed) and two different shRNA constructs against Trib3 and Bim, alone and in 
combination for three days. Counts of surviving neurons were performed at the indicated times 
and values are given as means ± S.E. (between four to ten independent experiments performed in 
triplicate) relative to the neuron number in cultures with NGF and control shRNA on each day. 





Trb3 over-expression is sufficient to promote neuron death in presence of NGF.  It has been 
shown that Trib3 has pro-apoptotic activity in several non-neuronal systems [137, 174].  
However, no data have been presented on whether Trib3 can induce death of NGF-responsive 
neurons. Lentivirally induced overexpression of Trib3 in both neuronal PC12 cells and SCG 
neurons (Fig. 2-4A, C) resulted in a steady decline in viability even though the cultures were 
maintained in the presence of NGF (Fig. 2-4B, D).  In order to determine whether cortical 
neurons, that are independent of NGF support, are also vulnerable to Trib3 expression, Trib3 was 
overexpressed lentivirally in cortical neuron cultures for various time periods (Fig. 2-4E, F).  
Overexpressing Trib3 did not result in cortical neuron death (Fig. 2-4E) indicating that not all 
neuron populations may be susceptible to Trib3. This finding also shows that the results obtained 
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Figure 2-4: Trib3 overexpression is sufficient to promote neuronal apoptosis. Replicate 
cultures of neuronal PC12 cells (A, B), SCG neurons (C, D) and cortical neurons (E, F) were 
infected with lentivirus expressing eitherTrib3+eGFP or eGFP (control) alone and maintained 
with NGF.  Cells were lysed after indicated time points and numbers of remaining intact nuclei 
were counted.  Cell lysates were also subjected to immunoblotting using antibody against Trib3 
and total ERK.  Panels (A, C, E) show representative blots.  Panels (B, D, F) show mean values 
of viable neurons +/- S.E. of three experiments for PC12 cells (B), four experiments for SCG 
neurons (D) and six experiments for cortical neurons (F) each carried out in triplicate. *p<0.005; 
**p<0.05; ***p<0.01; *¥p<0.0005; vs. time-matched control; Student’s t-test. 
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Trib3 regulates neuronal AKT phosphorylation. Trib3 is reported to bind AKT and block its 
phosphorylation, and therefore activity, in various non-neuronal cell types [130, 150-154].  The 
phosphorylation and activation of Akt is an important event because active Akt is necessary for 
neuron survival [53, 54].  NGF deprivation leads to Akt’s dephosphorylation and deactivation, 
contributing to neuronal death [54].  Given these facts, the logical next step was to determine 
whether or not Trib3 plays any role in the Akt dephosphorylation that follows NGF deprivation.  
Preliminary experiments in neuronal PC12 cells were carried out by infecting the cultures with 
lentivirus expressing control or shTrib3 constructs followed by NGF deprivation for 16 hours.  
Western immunoblotting for Akt phosphorylation at Ser473 and Thr308 (Fig. 2-5A) revealed 
that Akt dephosphorylation in response to NGF withdrawal was prevented by Trib3 knockdown, 
without affecting the total Akt levels.  Phospho-Akt levels were quantified after normalizing to 
total ERK and total Akt (Fig. 2-5B-F).  Similarly, endogenous Trib3 was knocked down in 
sympathetic neurons followed by 16 hours of NGF deprivation.  The decrease in Akt 
phosphorylation at both sites that occurs with NGF withdrawal was significantly reversed by 
Trib3 silencing (Fig. 2-6A, B) with no significant effect on total Akt levels under all conditions 
or on phospho-Akt in presence of NGF (Fig. 2-6C, D).  These findings support the idea that 
Trib3 expression due to NGF deprivation reduces Akt phosphorylation/activity, contributing to 
neuron death. 
In order to determine whether expressing Trib3 would be sufficient to mediate Akt 
dephosphorylation in neuronal PC12 cells and sympathetic neurons, the cells were infected with 
a Trib3-expressing lentivirus in the presence of NGF.  The levels of phospho-Akt were assessed 
by western immunoblotting 5 days after lentiviral infection.  In each case, levels of phospho-Akt 
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(both Ser473 and Thr308) decreased by about 40-60%, with no significant change in total Akt 
expression (Fig. 2-7 A-D).  Trib3 is therefore sufficient to cause Akt dephosphorylation in the 
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Figure 2-5:  Trib3 contributes to the decrease in Akt phosphorylation in neuronal PC12 
cells that occurs after NGF deprivation.  (A-F) Neuronal PC12 cell cultures were infected with 
lentivirus expressing shTrib3 or shRNA against dsRed (control).  72 hours post infection, NGF 
was removed for 16 hours and the neurons were lysed and lysates were subjected to SDS-PAGE 
and immunoblotted using the antisera against phospho-Akt (pT308 and pS473), total Akt and 
total ERK.  Panel (A) shows a representative immunoblot.  Protein levels quantified and 
































Figure 2-6:  Trib3 contributes to the decrease in Akt phosphorylation in SCG neurons after 
NGF deprivation.  (A-D) SCG neuron cultures were infected with lentivirus expressing shTrib3 
or sh_dsRed (control).  72 hours post infection, NGF was removed for 16 hours and the neurons 
were lysed and lysates were subjected to SDS-PAGE and immunoblotted using the antisera 
against phospho-Akt (pT308 and pS473), total Akt and total ERK.  Panels (A, C) show 
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independent experiments, each normalized against total ERK.  *p<0.05 compared to no NGF 


































Figure 2-7:  Trib3 expression is sufficient to reduce Akt phosphorylation.  Neuronal PC12 
cells (A, B) and SCG neurons (C, D) were infected with either control or Trib3 expressing 
lentivirus and maintained with NGF.  Five days after infection, cell lysates were subjected to 
SDS-PAGE and immunoblotted using antibodies against phospho-AKT (pSer473 and pThr308), 
total AKT and total ERK. Representative immunoblots are shown in panels (A) and (C); graphs 
(B) and (D) show mean values ± S.E. for 4-6 independent experiments, in each case normalized 
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Trib3 regulates phosphorylation of the Akt substrate FoxO1a.  The forkhead family of 
transcription factors includes well-described substrates of Akt.  In the presence of NGF, Akt 
phosphorylates the forkhead family member FoxO1a at Ser256 and Thr24 and this promotes its 
interaction with 14-3-3 proteins and sequestration in the cytoplasm [56, 58, 175].  Disruption of 
NGF signaling and consequent dephosphorylation/deactivation of Akt results in FoxO1a 
dephosphorylation, its dissociation from 14-3-3 proteins and its translocation to the nucleus [56, 
58, 175].  Once in the nucleus, Foxo1a transactivates pro-apoptotic genes such as Bim and 
contributes to neuron death [56, 63].  Because Trib3 induces Akt dephosphorylation when NGF 
is withdrawn, Trib3 should play a significant role in regulating phospho-FoxO1a levels under the 
same conditions.  To test this idea, preliminary experiments were performed in neuronal PC12 
cells.  The cells were infected with lentivirus expressing control or Trib3 shRNA and then 
examined for levels of phospho-FoxO1a 16 hours later. Western immunoblotting against 
phospho-FoxO1a and total FoxO1a (Fig.2-8A) revealed that there is about a 50% decrease in the 
levels of phospho-FoxO1a in response to NGF deprivation, but that this was fully rescued by 
Trib3 knockdown (Fig. 2-8B-D).   Findings were confirmed in sympathetic neurons that were 
also subjected to the same conditions, which revealed that levels of phospho-FoxO1a fell by an 
average of about 75% with NGF deprivation and control shRNA and that this was restored to an 
average of only 20% loss after Trib3 silencing (Fig. 2-9A, B).  There was an overall trend 
towards elevation of total FoxO1a levels after NGF deprivation, but this was not significant, nor 
was there a significant effect of Trib3 knockdown on levels of phospho-FoxO1a in presence of 
NGF (Fig.2-9 C, and D).   
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In addition, to test whether Trib3 is sufficient to mediate apoptosis in neuronal PC12 cells and 
SCG neurons by deregulating Akt substrates in the presence of NGF, FoxO1a phosphorylation 
was examined in NGF-treated cell cultures infected with lentivirus expressing Trib3.  This 
resulted in an approximate 50% loss of FoxO1a phosphorylation in both systems with no 
significant change in total FoxO1a levels (Fig. 2-10 A-D).  Taken together, these findings show 
that Trib3 significantly contributes not only to the fall in Akt phosphorylation triggered by NGF 






























Figure 2-8:  Trib3 contributes to FoxO1a dephosphorylation in PC12 cells after NGF 
deprivation.  Neuronal PC12 cells (A-D) were infected with lentivirus expressing shTrib3 or 
control shRNA.  72 hours post infection, NGF was removed for 16 hours and the cells were 
lysed and lysates were subjected to SDS-PAGE and immunoblotted using the antisera phospho-
FoxO1a, total FoxO1a and total ERK.  Panel (A) show representative blots.  Protein levels 
















































































































Figure 2-9:  Trib3 contributes to the decrease in FoxO1a phosphorylation in SCG neurons 
that occurs after NGF deprivation.  (A-D) SCG neurons were infected with lentivirus 
expressing shTrib3 or sh_dsRNA (control).  72 hours post infection, NGF was removed for 16 
hours and the neurons were lysed and lysates were subjected to SDS-PAGE and immunoblotted 
using the antisera against phospho-FoxO1a, total FoxO1a and total ERK.  Panels (A, C) show 
representative blots. Panels (B-D) show protein levels quantified relative to total ERK.   Mean 
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experiments (C, D), in each case normalized against total ERK. *p<0.005 compared to no NGF 

































Figure 2-10:  Trib3 expression is sufficient to reduce phosphorylation of FoxO1a in 
neuronal cells.  Neuronal PC12 cells (A, B) and SCG neurons (C, D) were infected with either 
control or Trib3 expressing lentivirus and maintained with NGF.  5 days after infection, cell 
lysates were subjected to SDS-PAGE and immunoblotted using antibodies against phospho-
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and (D) show mean values ± S.E. for 4 independent experiments, in each case normalized to total 




















Trib3 promotes and is required for FoxO1a’s translocation to the nucleus in response to 
NGF withdrawal.  As described above, an indirect effect of NGF deprivation is the 
dephosphorylation and consequent nuclear translocation of FoxO family members that drive 
neuron death via transactivation of pro-apoptotic genes such as Bim [56, 63].  Neuronal PC12 
cells were deprived of NGF for 16 hours and immunostained using total FoxO1a antibody.  This 
showed a more than 6-fold increase in the number of FoxO1a positive nuclei, confirming that in 
my hands FoxO1a does indeed localize to nuclei in the absence of NGF (Fig 2-11A, D).  Trib3’s 
effect on FoxO1a phosphorylation warranted an investigation into whether Trib3 also affects its 
nuclear translocation.  First, neuronal PC12 cells were infected with Trib3 lentivirus in the 
presence of NGF, which resulted in a nearly 5-fold increase in proportion of cells with detectable 
nuclear FoxO1a (Fig. 2-11B, D).   Thus, Trib3 expression is sufficient to drive nuclear FoxO1a 
translocation.  In order to determine whether silencing Trib3 would affect the nuclear 
translocation of FoxO1a that occurs in response to NGF deprivation, endogenous Trib3 was 
knocked down in neuronal PC12 cells.  After 16 hours of NGF deprivation, nearly all cells with 
control shRNA were positive for nuclear FoxO1a staining (Fig. 2-11C, D).  This was nearly fully 
prevented by knockdown of Trib3 (Fig. 2-11C, D).  Thus, Trib3 is required for the pro-apoptotic 
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Figure 2-11:  Trib3 regulates FoxO1a Nuclear Translocation.  (A) NGF withdrawal induces 
nuclear localization of FoxO.  Neuronal PC12 cells were either maintained in NGF or deprived 
of NGF for 16 hours and then subjected to immunostaining for FoxO1a.  ToproIII is used for 
nuclear staining.  NGF deprivation causes FoxO1a to translocate to the nuclei.  (B) Trib3 
overexpression promotes nuclear translocation of FoxO1a. Neuronal PC12 cells were infected 
for 5 days with lentivirus expressing either Trib3 or eGFP only (control) while maintained with 
NGF and then subjected to immunostaining for eGFP and FoxO1a.  (C) Trib3 is required for 
nuclear translocation of FoxO1a in response to NGF deprivation. Neuronal PC12 cells were 
infected with lentivirus expressing shTrib3 or sh_dsRed (control) for 72 hours and were either 
maintained with NGF or deprived of NGF for an additional 16 hours.  Cells were immunostained 
as indicated for GFP and FoxO1a. Scale bar = 20 µm.  (D)  Quantification of the effects of NGF 
withdrawal and Trib3 on nuclear translocation of FoxO1a.  Left-hand bars show the effects of 
NGF withdrawal and middle bars show the effects of Trib3 over-expression on nuclear 
translocation of FoxO1a with or without Trib3 over-expression.  Right-hand bars show the effect 
of Trib3 knockdown on FoxO1a nuclear translocation caused by NGF deprivation.  Conditions 
correspond to those in panels A, B and C, respectively.  Between 30 to 84 nuclei were blindly 
evaluated per culture.  Values are means ± S.E. for three independent experiments.  *p<0.001, 
compared with either no NGF (left hand bars), pWPI control (middle bars) or –NGF control 





Trib3 induction after NGF withdrawal requires FoxO transcription factors.  FoxO 
transcription factors participate in neuron death by transactivating pro-apoptotic genes, of which 
Bim has been the most studied [63, 64].  Examination of the  rat Trib3 promoter (using Gene 
Promoter  Miner ( http://GPMiner.mbc.nctu.edu.tw/) [176]  revealed two putative binding sites 
for FoxO transcription factors: ttTTGTTtgttt  and gttTGTTTgtttt within the 3kb region upstream 
of +1 initiation site. These binding sites look somewhat similar to the FoxO binding sites in 
mouse and human genes, which is TTGTTTAC [177].  Therefore, it is possible that FoxO plays 
a role in Trib3 regulation in the absence of NGF.  This hypothesis was tested in NGF-treated 
neuronal PC12 cells and sympathetic neurons that were infected for 3 days with lentivirus 
expressing either control or a previously described shRNA targeting FoxO family members 
including FoxO1a [178].  The relative Trib3 mRNA levels were quantified after an additional 16 
hours with or without NGF.  In both systems, FoxO silencing blocked the induction of Trib3 
mRNA caused by NGF removal (Fig. 2-12A, B).  Considering all the data so far, it is clear that 
Trib3 is essential for nuclear translocation of FoxO after NGF deprivation and that FoxO is in 
turn required for transcriptional induction of Trib3.  This suggests that Trib3 and FoxO are 




















Figure 2-12:  Regulation of Trib3 expression. (A, B) Induction of Trib3 in response to NGF 
deprivation requires FoxO.  Neuronal PC12 cells (A) and SCG neurons (B) were infected with 
shFoxO or control shRNA expressing lentivirus for 72 hours.   Cultures were maintained with or 
without NGF for an additional 16 hours for PC12 cells and 24 hours for SCG neurons. Total 
mRNA was isolated and quantitative PCR was performed using Trib3 primers.  Rat alpha-tubulin 
mRNA levels were used to normalize input cDNA.  Values are means ± S.E. of three (A) and 
one (B) independent experiments done in triplicate.  §p<0.05; ¥p<0.005; compared to -NGF 
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Akt deactivation triggers Trib3 induction and cell death.  Akt activity is required for neuron 
survival and Akt deactivation promotes neuron death in part by leading to FoxO 
dephosphorylation and consequent translocation of FoxO to the nucleus where it transactivates 
pro-apoptotic genes [56, 63].  Since the data above indicate that Trib3 is a FoxO target, it stands 
to reason that loss of Akt signaling should be sufficient to induce Trib3 transcription.  To test this 
idea, neuronal PC12 cells were treated with two drugs (Triciribine and 3-formylchromone 
thiosemicarbazone, Cu(II)Cl2 complex, also referred to as Akt inhibitor XI from EMD 
Bioscience) that inhibit Akt phosphorylation by different mechanisms [179, 180].  In the 
presence of NGF, concentrations of the drugs that block Akt phosphorylation (Fig. 2-13A) 
caused cell death at levels similar to those achieved by NGF deprivation alone (Fig. 2-13B).  The 
drugs also led to a significant induction of Trib3 transcripts under these conditions and as a 
positive control, it was found that there was an induction of Bim transcripts, as well (Fig. 2-13C).  
These observations thus indicate that the suppression of Akt signaling is sufficient to promote 
Trib3 induction, even in the presence of NGF.  Because Akt and Trib3 appear to negatively 
regulate one another, our findings suggest that the two are linked in a loop in which a decrease in 
Akt activity leads to induction of Trib3 that in turn depresses Akt activity and so forth. Although 
loss of Akt signaling may lead to activation of additional pro-apoptotic transcriptional pathways, 
these findings are consistent with the idea that Trib3 expression is controlled by a pathway that 




















Figure 2-13:  Akt Inhibition Upregulates Trib3 mRNA.  (A) Inhibition of Akt 
phosphorylation by various inhibitors.  Cell lysates of neuronal PC12 cells treated with various 
concentrations of Triciribine, and compound XI in the presence of NGF for 20 hours were 
subjected to SDS-PAGE and immunoblotted using antisera against phospho-Akt (pT308), total 
Akt, and ERK. (B) Inhibition of Akt activity promotes cell death.  Neuronal PC12 cells were 
treated with the indicated concentrations of Akt inhibiting drugs for 20 hours while maintained 
with NGF. Viable cells were then counted.  Values are means ± S.E. of three independent 
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NGF/DMSO.  (C) Akt inhibition induces Trib3 mRNA.  cDNA derived from cultures treated as 
in (D) were subjected to quantitative PCR using Trib3 and Bim primers.  Rat alpha-tubulin 
mRNA levels were used to normalize input cDNA. Values are means ± S.E. of three independent 

















The cell cycle and JNK pathways also appear to be required for Trib3 induction in 
response to NGF deprivation.  NGF deprivation leads to activation of multiple transcriptional 
pathways that ultimately promote induction of pro-apoptotic genes.  The most intensively studied 
pro-apoptotic target is Bim for which induction involves at least 5 different transcription factors 
and interference with any one of these pathways disrupts Bim induction by NGF deprivation [63, 
64, 68, 74, 79].  Two such pathways include the JNK and apoptotic cell-cycle pathways [69, 74, 
181].  c-Jun N-terminal kinases (JNKs) leads to c-Jun activation and c-Jun dependent Bim 
transcription [79].  Furthermore, examination of the rat Trib3 promoter revealed in addition to a 
potential FoxO binding site, sequences for potential binding of AP1/c-Jun and Myb.  The binding 
sequence identified for AP1/c-Jun is aTGACTca, which is very closely conserved in the human 
TRIB3 gene as TGAGTCA [182].  Three binding sequences for Myb were identified, as well: 
cAACTGtctgt, ccgtaCAGTTg and tAACTGagatt, two of which, appear to be conserved in the 
Trib3 gene of other species, including in humans, as C/TAACG/TG [183].  To assess whether 
this pathway is also required for Trib3 induction, Trib3 mRNA levels were measured in neuronal 
PC12 cells deprived of NGF in the presence or absence of the JNK inhibitors SP600125 (JNKi) 
[184] and D-JNKi-1 [185].  Both inhibitors blocked Trib3 induction caused by NGF withdrawal 
(Fig. 2-14).    In order to determine if the cell-cycle pathway is involved in Trib3 regulation, 
PC12 cells were treated with two different Cdk inhibitors, flavopiridol [186] and roscovitine 
[187].  They fully blocked Trib3 mRNA induction triggered by NGF withdrawal (Fig. 2-14).  
These findings support the idea that induction of Trib3 by NGF deprivation, as in the case of 
Bim, requires simultaneous activation of at least the FoxO, c-Jun and Myb transcriptional 
















Figure 2-14:  Inhibitors of JNK and Cdk4 suppress Trib3 mRNA induction in response to 
NGF deprivation.  Neuronal PC12 cells were treated with the Cdk4 inhibiting drugs roscovitin 
and flavopiridol and the JNK inhibitors SP600125 (JNKi) and DJnkI1 in the presence and 
absence of NGF for 16 hours. cDNA derived from the cultures was subjected to quantitative 
PCR using Trib3 primers. Rat alpha-tubulin mRNA levels were used to normalize input cDNA. 
*p<0.05, (four independent experiments performed in triplicate); **p<0.05, (two independent 
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NGF signaling via TrkA receptors is required for axonal growth, neuron survival and 
proper innervation by sympathetic and a subpopulation of sensory neurons of their targets [23].  
Its availability in limited supply during the latter part of development ensures that the correct 
number of neurons is involved in synapse formation and that supernumerary neurons that fail to 
form proper synapses are eliminated [8].  The intracellular processes leading up to neuron death 
at this stage of development is not fully understood.  The NGF deprivation model using neuronal 
PC12 cells and primary neonatal sympathetic neurons is an effective tool for studying the 
molecular mechanisms governing apoptosis; furthermore, since much of the mechanism is 
conserved in both developmental and pathological death paradigms, unlocking the mysteries of 
the former may help elucidate the mechanisms in the latter.  To date a number of pro-apoptotic 
genes have been studied, such as Bim, Hrk/Dp5, and EglN3/SM20 and their knockdown or 
deletion revealed that only partial protection from NGF deprivation is achieved, indicating that 
they are not fully accountable for mediating apoptosis [85, 87, 97].    One can certainly perform 
experiments where all of the above mentioned genes are simultaneously deleted and examine 
whether complete protection from NGF deprivation could be achieved; however, when Trib3 
was reported to be upregulated in the NGF-deprivation model and that it can interfere with Akt 
activity [113], it was important to follow up and determine its role in neuron death. The 
characterization of novel pro-apoptotic factors is desirable in that there is the likelihood of 
unveiling new mechanistic pathways within the apoptotic cascade.  This is especially important 
given the carefully controlled homeostasis of the neuron to ensure its survival; delineating the 
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functions of new genes can bring us closer to understanding how this homeostatic control is 
perturbed.   
Trib3 mRNA levels were significantly upregulated in PC12 cells and sympathetic 
neurons, which was first reported by Mayumi-Matsuda and colleagues in 1999.  This combined 
with reports of Trib3’s broad range of functions in cells and stress conditions and its active role 
in inducing apoptosis in non-neuronal cells, were instrumental in the decision to launch my 
investigation to understand the role of Trib3 in NGF-deprived neurons.  It was necessary to begin 
by reproducing the results of others and determine whether or not Trib3 mRNA and protein 
levels would be induced in my hands.  Depriving neuronal PC12 cells and primary sympathetic 
cultures of NGF over a few time points did indeed show that Trib3 is induced, both at mRNA 
and protein levels; this was later confirmed by Kristiansen et al. [163].  These initial experiments 
were also important for optimizing the culture conditions of our NGF-deprivation model in 
which the follow up experiments were performed.  Neonatal primary sympathetic cultures were 
used because during this developing phase, they are completely dependent on NGF for survival 
and undergo apoptosis in vivo.  Neuronal PC12 cells were used because as mentioned earlier, 
they mimic sympathetic neurons and are ideal for performing preliminary experiments. 
The question of whether or not Trib3 is involved in neuronal apoptosis was finally 
determined by endogenous Trib3 knockdown experiments in which significant protection from 
death was observed in both cell culture types.  Most impressively, the axons and processes of 
NGF-deprived SCG neurons were protected from degeneration and the overall morphologies of 
these neurons were maintained for a prolonged period nearly as well as those cultured in the 
presence of NGF. Trib3’s ability to protect axons is significant because often in pathological 
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neuron death, the demise of the neurons is usually initiated with axon degeneration and thus, 
protecting axons can potentially arrest neuron death [188].   
Knocking down endogenous Trib3 did not confer full protection possibly because there 
was a residual level of Trib3 still being expressed. Also the other transcriptionally upregulated 
proteins such as Bim, Hrk/DP5, PUMA or SM20 can participate in apoptosis [85, 88, 94, 189].  
Also, a recently transcriptome analyses under conditions of NGF deprivation revealed that 
numerous other genes are upregulated and any number of these molecules can potentially induce 
death [163].  Bim has been extensively studied in the NGF-deprivation model and was knocked 
down in this set of experiments, as well.  This protected neuronal PC12 cells to an extent that 
was comparable to Trib3 knockdown 1 to 2 days after NGF deprivation, but afforded only 
modest protection compared to Trib3 knockdown in sympathetic neurons.  Since neither Trib3 
nor Bim knockdown alone could afford complete protection, they were knocked down 
simultaneously, which did not result in significantly increased protection compared to that seen 
for Trib3 knockdown alone.  This indicates that perhaps Trib3 and Bim are functioning along the 
same apoptotic pathway in the neuron.     
One fundamental feature of the pro-apoptotic genes studied so far, such as Bim, Hrk/Dp5 
and SM20, is that they can induce death even when cultures were maintained in NGF [92, 95, 
190].  Trib3, too, has proved to be sufficient in inducing death in the presence of NGF, asserting 
itself as a bona fide pro-apoptotic protein.  Unlike the cases of neuronal PC12 cells and SCG 
neurons, overexpressing Trib3 in cortical neurons did not result in their death and this may be 
because either Trib3 does not play a role in their apoptosis or that Trib3 plays a role only under 
conditions of stress.  This latter possibility may conform with the observations made by 
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Mayumi-Matsuda et al., who reported that Trib3 cDNA levels were elevated in cortical neurons 
in response to Ca2+ ionophore excitotoxicity [113]. 
The present data indicate that Akt is a target of Trib3 in neurons.  Trib3 is necessary for 
Akt dephosphorylation in the absence of NGF and it attenuates phospho-Akt levels in the 
presence of NGF.  These experimental data from neuronal cells are in agreement with previous 
reports in which Trib3 has been shown to interact with Akt and result in its dephosphorylation in 
non-neuronal cell [130].  Akt phosphorylation at Ser473 and Thr308 residues is necessary for 
full Akt activation and survival of the neuron [53].  Upon NGF stimulation of TrkA receptors, 
Akt suppresses various pro-apoptotic molecules and pathways, such as FoxO transcription 
factors that are phosphorylated and sequestered in the cytosol [56].  I found that FoxO1a is 
deregulated by Trib3 during NGF withdrawal.  This must be a consequence of Trib3 mediated 
dephosphorylation of Akt.  Trib3 knockdown rescued FoxO1a from dephosphorylation when 
NGF was withdrawn and conversely Trib3 overexpression in the presence of NGF reduced the 
levels of phospho-FoxO1a.  In line with FoxO1a’s phosphorylation status dictating whether or 
not the transcription factor will translocate to the nucleus, I found that Trib3 mediated 
dephosphorylation of FoxO1 promoted its nuclear translocation, which was inhibited by Trib3 
knockdown.  Thus, the aforementioned findings regarding Trib3, Akt and its substrate FoxO1a 
correlate with the observations that Trib3 knockdown is protective and that its overexpression is 
deleterious for neuronal cells.     As a form of programmed cell death, apoptosis resulting from 
NGF deprivation requires that new transcription and translation events take place [1].  In the 
absence of NGF, the FoxO, JNK, and apoptotic cell-cycle transcriptional pathways are among 
several regulatory pathways that are activated, inducing pro-apoptotic genes [56, 63, 69, 79].  I 
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found that Trib3 is transcriptionally regulated by FoxO transcription factors in both neuronal 
PC12 cells and sympathetic neurons.  Treating neuronal PC12 cells with drugs that inhibit CDK4 
and JNK activity, suppressed Trib3 mRNA induction in the absence of NGF, suggesting that 
these pathways may be necessary, as well.  The observations confirm reports made by 
Kristiansen et al., where MLK inhibitor CEP-11004 suppressed Trib3 transcription during NGF 
deprivation [163].  In the case of Bim, its induction requires the FoxO, JNK, apoptotic cell-cycle, 
and NF-Y pathways [63, 64, 68, 74, 79].  Other pro-apoptotic genes, HRK/DP5 and SM20 are 
transcriptionally upregulated by the JNK pathway [96, 170].  Thus, the results regarding Trib3 
regulation in NGF deprived cells conform to this model and as predicted, show that Trib3 is 
indeed in a feedforward loop with the FoxO transcription factors.   
If Akt regulates FoxO activation and Trib3 is transcriptionally induced by FoxO, then 
Akt deactivation must lead to Trib3 induction.  As expected, treatment of neuronal PC12 cells 
with Akt inhibiting drugs upregulated Trib3, showing that Trib3 is in a negative feedback loop 
with Akt.  Interestingly, Trib3 induction resulting from Akt inhibition was much greater 
compared to what has been observed after NGF deprivation.  This probably indicates that NGF 
deprivation alone is not sufficient for complete Akt deactivation in the neuron.  This is not 
unusual because Akt phosphorylation and activation are not solely dependent on NGF/TrkA 
activity.  Akt can be phosphorylated in response to a number of growth factors and trophic 
factors binding to their respective receptors and/ or Trk and both SCG neurons and PC12 cells 
express many of the necessary receptors [43-46].  NGF deprivation may result in Akt 
deactivation to a degree that is sufficient to induce Trib3 and initiate the apoptotic cascade. 
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Collectively, the experimental data lead to the formulation of a model delineating Trib3’s 
mechanism in the neuron (Fig. 2-15).   During NGF stimulation of TrkA receptors, Akt is 
phosphorylated and inhibits its substrate FoxO via phosphorylation (A).  NGF deprivation results 
in an initial decrease in the level of phospho-Akt that leads to dephosphorylation of FoxO 
transcription factors, leading to its nuclear localization (B).  In the nucleus FoxOs transactivate 
Trib3 and upregulated Trib3 binds to Akt, leading to further dephosphorylation and deactivation 
of Akt, thus amplifying the effects of NGF deprivation (C).  Due to the further inactivation of 
Akt, activated FoxOs may reach a critical level at which they can induce other pro-apoptotic 
genes, such as Bim that can play a more direct role in the mitochondrial intrinsic pathway, 
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A Model of How Trib3 May Mediate Apoptosis in Sympathetic Neurons Deprived of NGF 
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Thus, we see from the above model that there is a self-propelled pathway that amplifies 
the initial stress caused by the absence of NGF.  But why would such a self-amplification loop be 
necessary?  In the developing embryo, NGF is released in limited quantity by targets as the 
immature SCG neurons begin to innervate them [39].  The SCG neurons become dependent on 
NGF for survival and compete for its limited supply, which selects for the correct number of 
neurons to match the size of their innervating target organ [8].  As we have discussed in chapter 
1, NGF signaling closely regulates numerous intracellular events in the neuron via the PI3K/Akt 
pathway in order to ensure survival and maturation, placing Akt at the helm of the survival 
mechanism [23, 42, 43].  It is then logical that when a neuron fails to compete for its target-
derived NGF support, the quickest and most effective way to trigger the apoptotic event would 
be to deactivate Akt.  The model presented here describes the mechanism of Trib3 that is very 
effective in rapidly amplifying Akt deactivation shortly after a loss in NGF signaling is detected 
by the neuron, upsetting its homeostatic balance and inducing transcriptional mechanisms 










Neuron Death in the Trib3 KO Mouse SCG 
 
Introduction 
A number of researchers have found that the Trib3 protein interferes with insulin 
signaling by negatively regulating Akt phosphorylation and activation, leading to glucose 
intolerance and insulin resistance [130, 151-153].    Under normal conditions, Akt is activated as 
a result of insulin binding to its receptor and leads to Akt mediated phosphorylation and 
suppression of gluconeogenic enzymes, PEPCK1 (phosphoenopyruvate) and G6P (glucose-6-
phosphatase) [40].  Akt also inhibits glycogen synthesis by phosphorylating and deactivating the 
kinase GSK3β (glycogen synthase kinase-3 β).   To understand the role of Trib3 in vivo, 
Okamoto et al created Trib3 deletion mutant mice by substituting in a LacZ/neomycin cassette as 
shown below (Fig. 3-1) [191].  
 
When examined for body composition, insulin signaling, glucose and lipid metabolism, the 
Trib3-/- mice showed no differences compared to their WT littermates [191]. 
Figure 3-1 
Generation of Trib3-/- mice.  Schematic 
diagram of the murine wild-type (WT) Trib3 
allele and the targeting vector used to 
generate a null Trib3 allele by precise 
substitution of the lacZ reporter gene as well 
as a neo-selectable marker.  Yellow boxes, 
homology boxes, homology boxes; red 
boxes, coding exons. 
Okamoto et al. 2007 
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The group also showed that the glucose and glycogen levels after 24 hours of fasting 
were normal and that administration of an insulin bolus resulted in a comparable increase in the 
basal levels of phospho-Akt between the two genotypes; no differences in insulin-induced 
GSK3β phosphorylation were observed either, indicating that Akt activity was not affected by 
Trib3 deletion [191].  Previously, Trib3 overexpression was linked with the development of 
glucose intolerance and a reduction in liver glycogen content [130].  Interestingly, a comparison 
between WT and Trib3-/- mice revealed that under insulin fasted conditions, no differential 
expression pattern in genes involved in hepatic glucose production can be observed; the genes 
that were examined here include Pepck, G6p, and Pgc1α [191].  Liver glycogen levels were also 
found to be comparable between these two genotypes, suggesting normal glucose metabolism 
[191].  A link between Trib3 expression and lipid metabolism was described earlier, where Trib3 
mediated degradation of ACC, an enzyme necessary for biosynthesis of fatty acids [149].  In 
Okamoto el al., ACC levels were the comparable between the WT and mutant mice; moreover an 
examination of the expression levels of genes involved in regulation of fatty acid oxidation, such 
as Pparα, Pgc1α and Ucp1, failed to reveal any dissimilarities [191].  Because they did not 
observe any deviation in Akt phosphorylation, activity and in glucose or energy homeostasis in 
these Trib3-/- mice compared to the WT littermates, the authors concluded that loss of Trib3 was 
insufficient to modify glucose and lipid metabolism; however, they maintained that it may still 
be possible that Trib3 is important in other contexts and proposed that Trib3-/- mice be utilized 
in examining the consequences of Trib3 ablation in various stress conditions [191].  This was of 
interest for two reasons: one, the group did not examine the effects of Trib3 deletion in the 
nervous system, or at least did not report any observations regarding the nervous system and two, 
developmental PCD in SCG does result from stress conditions arising from trophic factor 
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deprivation.  Since my experimental data so far have demonstrated that Trib3 is necessary for 
developmental neuron death in cell culture models, it was important to ask what effect Trib3 
deletion would have on the level of apoptosis in SCG neurons in vivo.  Unlike what had been 
observed in caspase-3 and -9 knockout mice, sometimes deleting a proapoptotic gene can have 
subtle effects that are not readily discernible.  For example, Bax deletion did not produce any 
grossly abnormal phenotype in mice; however, a close examination revealed that the SCG 
contained supernumerary neurons that underwent apoptosis at a slower rate in culture without 
NGF; moreover, their soma were half the size of WT neurons [101].  Therefore, it is possible that 
the rate or extent of apoptosis in Trib3 knockout SCG neurons will deviate significantly from 
that of the WT neurons.     
Hypothesis 
If Trib3 is necessary for inducing death in cell cultures after NGF deprivation, 
developmental death in Trib3 knockout sympathetic neurons may be aberrant or proceed 
at a slower rate.  Neuron death is delayed in sympathetic neurons from Bim, Dp5, SM20 and 
Bax knockout mice without resulting in gross deformities [85, 87, 97, 101].  Therefore, Trib3-/- 
can potentially affect the rate or level of developmental PCD in these neurons in vivo without 
giving rise to any noticeably abnormal phenotype.  My experimental data show that the loss of 






Trib3 deletion does not appear to alter the extent of apoptosis in developing SCG neurons.  
In mice and rats, SCG neurons become exclusively dependent on NGF for their survival 
beginning at approximately ages E15 and E12-13, respectively and this dependency on NGF 
reaches its peak during the neonatal stages of life [39, 192, 193].   PCD occurs in the neonatal 
mice and rats as the neurons compete for a limited supply of target derived NGF [194, 195].  In 
order to examine whether Trib3 deletion would alter this normal course of development, SCG 
neurons from both WT and mutant mice were analyzed at age P1 (postnatal) and P7.  DNA 
strand breaks occur during the final stages of apoptosis and results in phosphorylation of 
histone2A; using anti-sera against phospho-H2AX gives positive staining in neurons that are 
undergoing apoptosis and therefore, serves as an effective marker for identifying apoptotic 
neurons [196].  5 µm thick sections of the right and left superior cervical ganglia were 
immunostained against phospho-H2AX protein (Fig. 3-2A, B).  The densities of apoptotic 
(pH2AX positive) neuron population were determined and plotted (Fig. 3-2E).  When compared 
with WT mice, the Trib3-/- SCG displayed no significant differences in the density of apoptotic 
sympathetic neurons at both ages (Fig. 3-2E).  These observations suggest that Trib3-/- SCG 
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Figure 3-2:  Trib3 deletion does not affect the extent of apoptosis in developing SCG 
neurons. Both the right and left SCG from neonatal (P3 and P7) mice were sliced into 5 µm 
thick sections.  25 such sections were made obtained from each ganglion and every 5th section 
was stained with hematoxylin and eosin.  The remaining 20 sections were immunostained with 
an antibody against phosphophorylated H2AX protein in order to identify sympathetic neurons 
undergoing apoptosis. All pH2AX positive neurons were counted in each section, excluding any 
neurons that appeared in the previous section and already counted in order to avoid counting 
them twice.  The sum of pH2AX positive neurons from all 20 sections of a single ganglion was 
then divided by the sum of the area of all 20 sections in order to normalize to the area and 
determine the density of pH2AX stained neurons.   Panel (E) represents mean density values ± 
S.E.   n=8 for P3 and n=3 for P7 animals. 











An examination of superior sympathetic ganglionic sections of WT and Trib3-/- mice failed 
to show any differences in the numbers of apoptotic neurons at ages P3 and P7.  These in vivo 
results are in contrast with the in vitro data presented in Chapter 2, where cultured WT rat SCG 
neurons required Trib3 in order to undergo apoptosis in the absence of NGF.  This apparent 
discrepancy could be due to compensatory mechanisms.  Compensation in gene function is not 
uncommon in biological systems and a good example of this phenomenon is caspase-2.  RNAi 
knockdown of caspase-2 protected SCG neurons from NGF deprivation, whereas a genetic 
deletion did not [109].  The caspase-2 null neurons underwent apoptosis as usual, employing a 
compensatory mechanism, in which the caspase-9/caspase-3 pathway was activated [109].  The 
Trib3-/- sympathetic neurons appeared to undergo apoptosis as well as the WT neurons, but what 
may account for it?   Though I have not examined the levels of phospho-Akt in these neurons, 
Okamoto et al. have in liver cells after insulin injection and reported no alterations [191].  It is 
highly probable that Akt phosphorylation and dephosphorylation events are taking place in the 
mutant neurons just as well as in the WT neurons.  Therefore, a limited supply of NGF is 
effectively triggering the apoptotic cascade in the neonatal SCG neurons most likely via Akt 
dephosphorylation as one would expect.  In the absence of Trib3, this may be being 
accomplished by other proteins.  As discussed in Chapter 1, Akt activation is regulated by a 
number of proteins and kinases that can enhance or suppress Akt by either binding to Akt or by 
post-translationally modifying it.  One such protein is CTMP (carboxy-terminal modulator 
protein).   It is a 27 kDa protein that has been shown to bind Akt at its c-terminus region, which 
include the HM (hydrophobic motif) and c-term phosphorylation site [40, 197].  CTMP’s 
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interaction with Akt resulted in dephosphorylation of both the T308 and S473 residues and 
sensitized HeLa and HEK293 cells to apoptosis even in the presence of insulin or IGF-1 [197].  
Thus, CTMP could potentially replace Trib3 in the mutant sympathetic neurons and mediate 
apoptosis.   
Aside from showing that Trib3 can bind with Akt and promote its dephosphorylation, Du et 
al. reported that a second member of the mammalian Tribbles family, Trib2, can bind Akt and 
result in its dephosphorylation, as well [130].  Trib2 was never reported by anyone as being 
involved in cell death and has been shown to be involved in cancer cell metastasis [118].  In any 
case, it is also possible that Trib2 is compensating for Trib3 deletion in the neurons.    
Another source of compensation could involve factors that normally play an auxiliary role in 
regulating Akt.  Non-receptor tyrosine kinases, such as Ack1 and Src, can phosphorylate various 
tyrosine residues on Akt, which are thought to induce a conformational change in Akt and 
enhance its phosphorylation at the T308 and S473 residues [59].  There are also a number of 
serine/threonine kinases, such as IKBE, TBK1 and DNA-PK, that can phosphorylate Akt on 
various threonine and serine residues including the all-important T308 and S473 residues directly 
in a PI3K-independent manner [59].     
  
Figure 3-3 
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Under normal conditions, some of these kinases are thought to work as backups in their abilities 
to directly phosphorylate the T308 and S473 sites independently of PI3K; nonetheless they 
provide additional controlling mechanisms for Akt activation and deactivation.   In a mutant cell 
lacking a necessary gene for Akt deactivation, such as Trib3, these kinases can potentially play a 
more prominent role as they respond to lack of trophic support by being deactivated themselves 
and failing to promote Akt phosphorylation and activation, leading to apoptosis.   
Kinases are not the only molecules to regulate Akt activation; phosphatases also play a 
key role.  A well-defined phosphatase that dephosphorylates Akt is PP2A (protein phosphatase 
2A) [43, 198].  PP2A consists of a catalytic, a regulatory and an array of substrate specificity 
subunits known as subunits B [43].  Together, these subunits form trimeric holoenzymes that can 
be of 75 different types, depending on the type of B subunit that participates in the complex; 
thus, enabling PP2A to target a wide variety of substrates under various conditions [43].  Akt is 
targeted by PP2A usually as a result of p75NTR stimulation and dephosphorylates the T308 and 
S473 residues [43].  It is a possibility that PP2A molecules are playing an important role in 
dephosphorylating Akt in Trib3-/- sympathetic neurons in vivo when they fail to compete for 
NGF. 
Finally, there is also the possibility that Trib3 does not play a role in neuron death in vivo.  
Neurons grown in the artificial environment of cell-culture dishes may not behave the same way 
as in the natural environment within a biological system and Trib3 may play an important role in 
vitro only.  The aforementioned molecules may compensate for Trib3 in vivo because Trib3 is 
truly necessary but absent, or they may function in vivo as they normally do regardless of Trib3’s 
involvement.  An alternate method can be utilized, one that may provide little opportunity for 
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compensation, in order to clarify whether or not Trib3 is truly necessary in vivo.  This will be 


















Preliminary Evidence that Trib3 is Involved in Neurodegenerative Diseases 
Introduction 
Parkinson’s disease (PD) and Alzheimer’s disease (AD) are progressive 
neurodegenerative diseases consisting of both sporadic and familial forms [21, 188].  In PD there 
is a progressive loss of midbrain dopaminergic (DA) neurons from the substantia nigra pars 
compacta (SNpc) with an accumulation of intracellular inclusions called Lewy bodies [188].  
Neurons in other structures of the PD brain, such as the locus coeruleus, cerebral cortex, and 
amygdala and the peripheral sympathetic ganglia also exhibit Lewy bodies [188, 199].  In 
patients, PD manifests itself as impaired motor function due to resting tremor, rigidity, 
bradykinesia, abnormal posture and gait, symptoms known as cardinal motor symptoms [200].  
In advanced stages of PD, patients may develop non-motor symptoms, such as sleep 
disturbances, anxiety, depression and cognitive decline [200].  While specific gene mutations 
that are associated with familial PD are in process of being characterized, the most common 
form, sporadic PD, has no proven etiology [164, 201]. However, environmental factors such as 
pesticide exposure, rural living and well water consumption have been identified by 
epidemiological studies to be risk factors for developing sporadic PD [164].  In laboratories, 
sporadic PD is studied using toxin-based animal and cell culture models.  These toxins included 
MPTP (1-methyl-4-phenyl-12,3,6-tetrahydropyridine) and 6OHDA (6-OHDA) both of which 
cause almost complete destruction of SNpc and catecholaminergic neurons and Parkinsonian 
symptoms in animal models [164, 199, 201, 202].  These molecules induce apoptosis by 
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respiratory poisoning in that they disrupt complex I and other components of the ETC (electron 
transport chain) of mitochondria, resulting in oxidative stress [164, 201, 202].  The relevance of 
toxin-based cell culture models, which also include neuronal PC12 cells, to PD are supported by 
biochemical and histological studies of post mortem PD brain, where there is evidence of 
decreased complex I activity and oxidative stress in the SNpc neurons [55, 202].  In one such 
toxin-based study, SAGE (serial analysis of gene expression) procedure revealed there was an 
induction in Trib3 mRNA levels in PC12 cells after treatment with 6OHDA, suggesting Trib3 
may be involved in Parkinsonian neurodegeneration [164].    
AD is characterized by formation of neurofibrillary tangles and Aβ (amyloid-β) plaques, 
resulting in death of the cholinergic neurons of the basal forebrain and in development of 
cognitive impairments [21, 24].  Aβ plaques are evident in both familial and sporadic forms of 
the disease and the principal constituents of amyloid deposits are Aβ1-42, which is derived from an 
abnormal processing of the amyloid precursor protein (APP) that is normally present in the 
neuron [24].  Aβ1-42 production causes the formation of fibril aggregates that increase in size, 
ultimately forming plaque-like deposits that lead to apoptosis.  The cellular mechanisms leading 
to neuron loss in the AD brain can be reproduced in laboratory settings by treating neuronal 
PC12 cells or primary cultures of cortical or hippocampal neurons with Aβ1-42 preparations [203].  
As discussed in Chapter 1, pro-apoptotic molecules and their associated pathways that lead to 
pathological death are often conserved in developmental neuron death.  The pro-apoptotic Bim 
plays a significant role in both NGF deprivation-related death and is elevated in neurons from 
AD brain and in AD culture models [85, 168].  Another pro-apoptotic molecule, Hrk/DP5 
promotes death after motor neuron injury and in ALS (Amyotropic Lateral Sclerosis) well as in 
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response to NGF deprivation and requires the JNK pathway for activation [88, 169, 204].  
Similarly, since Trib3 has been proven to be an integral part of the apoptotic cascade in the NGF-
deprivation model of developmental death and is induced in a PD toxin model, it may possibly 
play a role in the Aβ model, as well.  Therefore, I proceeded to explore, in preliminary 
experiments, the role of Trib3 in two pathological neuron death paradigms. 
Hypothesis 
Trib3 plays a role in apoptosis resulting from 6OHDA and Amyloid β toxicity.  Trib3 
mRNA levels are upregulated in response to 6OHDA treatment in neuronal PC12 cells as 
revealed by SAGE [164] .  Many factors that are involved in NGF deprivation-related death are 
involved in pathological neuron death, as well.  Therefore, it is also possible that Trib3 is 
involved in both developmental and pathological neuron death.  My preliminary findings support 
this idea by showing that Trib3 is induced in cellular models of PD and AD and is necessary for 
mediating death in these models. 
Results 
Trib3 is involved in pathological neuron death  
This hypothesis was tested in the following manner: neuronal PC12 cells were treated 
with various concentrations of 6OHDA for 10 hours (Fig. 4-1A) or amyloid β for 20 hours (Fig. 
4-1B).  Quantitative PCR revealed that Trib3 transcript levels increase by approximately 4 fold 
with 6OHDA treatment and about 2.5 fold following amyloid β treatment.  In order to determine 
whether Trib3 was necessary for inducing apoptosis in these cell death paradigms, endogenous 
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Trib3 was knocked down in neuronal PC12 cells prior to treatment with 6OHDA or an Aβ 
dodecamer preparation (Fig. 4-1 C, D).  Knocking down Trib3 conferred significant protection 
from death in these cells:  the number of apoptotic cells resulting from 6OHDA toxicity was 
greatly reduced (Fig. 4-1C) and the number of viable cells in cultures treated with amyloid β 
dodecamer remained plentiful (Fig. 4-1D).  Thus, Trib3 plays a necessary role in pathological 


























































































































Figure 4-1:  Trib3 is involved in pathological neuron death.  (A, B) Trib3 is induced in AD 
and PD toxin models.  Neuronal PC12 cells were treated with indicated concentrations of 
6OHDA for 10 hours (A) or 10 µM Aβ dodecamer for 6 hours (B).  Total mRNA was isolated 
and subjected to reverse transcription followed by quantitative PCR using Trib3 primers.  Rat 
GAPDH and alpha-tubulin mRNA levels were used to normalize input cDNA. The data are 
reported as relative increase in mRNA levels normalized to NGF control in a single experiment.  
(C, D)  Trib3 is necessary for death induced by 6OHDA and Aβ toxicity.  Neuronal PC12 cells 
were transfected with either control shRNA (sh_dsRed) or shRNA against Trib3 for 48 hours 
followed by treatment with 100 µM 6OHDA for 18 hours while maintaining them in NGF.  Cells 
were then fixed with 3.7% formaldehyde and stained with Hoechst 33342 dye.   Transfected 
(GFP+) cells with pyknotic nuclei were counted in random fields under an epi-fluorescent 
microscope and the percentage of apoptotic cells determined.  (C) Mean values of three 
independent experiments done in triplicate are plotted ± S.E.; *p<0.05.  Neuronal PC12 cells 
were infected with lentivirus expressing either control shRNA (sh_dsRed) or shRNA against 
Trib3 for 72 hours followed by treatment with 10 µM Aβ dodecamer preparation or vehicle for 
48 hours while maintaining them in NGF.  Cells were then lysed and the numbers of intact nuclei 
were counted and percentage of viable cells determined.  (D) Mean values of three independent 







Administration of the PD toxin 6OHDA or Aβ1-42 fibrils to neuronal PC12 cells resulted 
in an appreciable increase in the Trib3 transcript levels as predicted, and confirms the 
upregulation of Trib3 mRNA in the 6OHDA toxin model as reported in Ryu et al. [164].  
Furthermore, it is presented here that Trib3 is indeed necessary for inducing apoptosis in both the 
PD and AD models of neuron death.  In the SAGE study, there are reports of several other genes 
becoming induced, including ATF4 and CHOP, two well-established transcriptional inducers of 
Trib3 [131, 133, 134, 164].  This is not surprising since 6OHDA toxicity also leads to ER stress 
and elicits the UPR [205].  As discussed in Chapter 1, numerous researchers have already 
reported that both CHOP and ATF4 act together to induce Trib3 during ER stress in various non-
neuronal cells [131, 133, 134]; therefore the data presented here are in agreement with previous 
findings and appear to suggest that Trib3’s induction in response to 6OHDA may be 
transcriptionally regulated by ATF4 and CHOP.  It is possible that, similarly to what I observed 
with NGF deprivation, Trib3, ATF4, and CHOP are acting in a self-regulatory manner in 
neuronal cells treated with 6OHDA [131, 133, 134].  
Trib3 is induced and appears to be necessary for death in Aβ1-42 in vitro model of AD, 
providing support for Trib3’s possible involvement in Alzheimer’s disease and warrant further 
investigation.  That Trib3 should be involved in neuron death both during development and 
Alzheimer’s disease is not unusual because Bim, an intensively studied pro-apoptotic protein, 
has been reported to induce apoptosis in both paradigms, as well [168].  Furthermore, the 
apoptotic cell-cycle pathway that appears to regulate Trib3 during NGF deprivation and may do 
so in AD model, as well since the pathway has been shown to transactivate Bim in response to 
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Aβ1-42 treatment [168].  This chapter presented preliminary experimental findings that show that 
Trib3 is involved in cell culture models of neurodegenerative disease.  These preliminary results 
have prompted other collaborating researchers to pursue this line of investigation, which will be 

















Conclusions and Future Directions 
Trib3’s Involvement in Developmental Death of SCG Neurons 
Developmental death resulting from a limited supply of NGF is a necessary process by 
which superfluous neurons are eliminated, allowing formation of precise and functional target 
innervation [8, 9]. The apoptotic process leading up to this neuron death is complex and requires 
de novo transcription and translation of numerous genes and activation of various pathways [1].  
Using the in vitro NGF-model, which has been instrumental in identifying and elucidating 
various pro-apoptotic proteins and their associated pathways, the experimental data presented 
here demonstrate that Trib3 is a novel neuronal pro-apoptotic gene.  It employs a mechanism 
involving Akt and FoxO, in which the initial apoptotic signal is rapidly amplified, leading to 
death.  In targeting Akt, Trib3 deregulates and activates its effector FoxO, which in turn results 
in further upregulation of Trib3, Akt deactivation and FoxO activation, leading to FoxO-
dependent induction of downstream pro-apoptotic genes and apoptosis.  This model would 
explain how suboptimal levels of NGF during development would be detected by the neuron and 
readily initiate the apoptotic cascade.  The data also raise a number of questions and possibilities 
for future experiments.  First, simultaneous knockdown of Trib3 and Bim did not afford 
significantly greater protection from death than Trib3 knockdown alone and therefore it was 
concluded that they may be working along the same pathway.  Also, since FoxOs can induce 
Bim when NGF is withdrawn [63, 64], my data regarding Trib3’s ability to mediate FoxO1a 
activation support the idea that Trib3 and Bim may be functioning along the same pathway.  Bim 
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is transcriptionally regulated by FoxO and Trib3 activates FoxO and induces its nuclear 
localization [63]; therefore it appears that Trib3 is functioning, at least in part, upstream of Bim 
induction.  This hypothesis can be tested by knocking down endogenous Trib3 in neuronal PC12 
cells or SCG neurons, withdrawing NGF and examining what happens to Bim protein levels.  
Bim is highly induced in response to NGF withdrawal [85] and if Bim is indeed being indirectly 
regulated by Trib3, then the increases in its transcript and protein levels that occur after NGF 
deprivation should be suppressed.   
NGF deprivation for 16 to 18 hours causes approximately 50 percent of neuronal PC12 
cells and SCG neurons to undergo apoptotic death in culture [101].  It has been shown here that 
Trib3 is required for this apoptosis.  Curiously, it was observed that 6 days of Trib3 
overexpression was required to reach a 50 percent decrease in viability of SCG neurons.  This 
delay is also observed in the rate of Akt and FoxO1a dephosphorylation (Fig 7 and 10) by Trib3 
in the presence of NGF and no doubt correlates with the rate of death.  The question that is raised 
is why is there a delay?  A potential explanation may be that as NGF deprivation brings about a 
significant change in neurons by activating certain genes and pathways while suppressing others, 
the conditions lead to some sort of modification of Trib3 protein.  This could be either a post-
translational modification or an enhanced interaction with a binding partner of some sort, leading 
to increased activity. The physiologic conditions during NGF deprivation may be more 
permissive for Trib3 to become modified in a way that affects its activity and this may lead to the 
deactivation of Akt with increased efficacy.  Trib3 has been reported to become post-
translationally modified in muscle cells subjected to chronic exposure to ethanol. These cells 
displayed hypoacetylated Trib3, reduced levels of Akt dephosphorylation and insulin resistance 
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[153].  Whether or not Trib3 is post-transnationally modified in the absence of NGF can be 
tested by subjecting the cell lysates of NGF deprived SCG neurons to two-dimensional protein 
electrophoresis followed by immunoblotting with anti-Trib3.  Trib3 also has quite a few binding 
partners and it is speculated that it functions as an adaptor or scaffolding protein in that it utilizes 
its trb domain to bind and recruit various proteins to form a functional complex (Boudeau 2006) 
[206].  Thus, it is also possible that Trib3 recruits factors that are induced or become available 
following NGF deprivation and that formation of such a multimeric complex effectively leads to 
Akt dephosphorylation.  In the presence of NGF, such a permissive environment may be slow to 
be achieved and an excess level of exogenous Trib3 is not as efficient.  Therefore, ectopic 
expression of Trib3 is sufficient in recapitulating apoptotic events in SCG neurons albeit at a 
slower pace.  The nature of any possible binding partners for Trib3 other than Akt would be a 
worthwhile topic for future investigations and can be performed by utilizing a yeast-two hybrid 
assay using cDNA library of NGF-deprived neuronal PC12 cells and/or SCG neurons. 
As discussed in Chapters 1 and 2, one of the hallmarks of trophic factor deprivation-
related apoptosis is the activation of various transcriptional pathways and blocking these 
pathways protects neurons from death [1].  This point has also been demonstrated in this body of 
work by showing that Trib3 induction requires FoxO and appears to be regulated by the JNK and 
the apoptotic cell-cycle pathways.  This investigation was also initiated in part because an 
examination of a 3kb region upstream of the +1 site of Trib3, showed that the regions contains 
putative binding sites for FoxO, AP-1, and mybs, some of which are conserved in mice and 
humans.  One way to pursue this topic further would be to examine whether or not the 
transcription factors do indeed bind to Trib3’s promoter.  This can be done using chromatin-
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immunoprecipitation assays.  Furthermore, the roles of the newly emerging transcription 
pathways, NF-Y and p53/p63/p73 [66, 68, 81], in inducing Trib3 should also be examined, 
which can be accomplished by knocking down the transcription factors associated with these 
pathways, namely NF-Y, p53 and p63, and observing the effect on Trib3 transcription in the 
absence of NGF.  A luciferase reporter (Renilla luciferase cDNA spliced at the 3’ end of the 
Trib3 promoter) assay, which was instrumental in understanding Bim regulation [64], would be 
very effective in examining the direct actions of the transcription factors under physiologic 
conditions in NGF-starved neuronal PC12 cells. 
Trib3 Deletion and its Effect in Developmental Death in vivo 
An examination of neuron death in the superior cervical ganglia of Trib3-/- mouse [191] 
was included in this study because it provided an opportunity to examine the role of Trib3 in 
developmental death in vivo.  No apparent differences in the extent of apoptosis could be 
observed in the SCG neurons of the mutant versus the WT mice.   There may be two 
explanations for this: one, the Trib3 gene is not necessary in vivo in mice for inducing NGF 
deprivation-related developmental death or two, Trib3 may be necessary, but a genetic 
compensation of some sort has occurred.   At present, it cannot be concluded with certainty that 
Trib3 is not necessary for mediating developmental death in vivo.  An alternate method should be 
employed in examining the significance of Trib3 in vivo.  Conditional knockouts would be an 
ideal method in that the gene can be deleted with ease during the neonatal stage of natural PCD 
and the effects can be observed shortly after the deletion, leaving little opportunity for the system 
to compensate.  For this, transgenic mice with loxP-Trib3 and tamoxifen induced Cre 
recombinase can be constructed.  Trib3 can be deleted specifically in adrenergic neurons, such as 
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those in the SCG, by placing the expression of the Cre recombinase under the control of the 
DBH promoter (dopamine β-hydroxylase) [207].    
Trib3’s Potential Involvement in Neurodegenerative Diseases 
Developmental apoptotic processes are often recapitulated in neurodegenerative diseases 
and I have presented data showing that Trib3 is required in the 6OHDA and Aβ models of 
neuron degeneration.  My collaborators, Drs. Pascaline Aime and Paulette Bernd, have found 
that Trib3 protein is upregulated in primary ventral midbrain (VM) DA neuron cultures after 
treatment with lethal concentrations of MPP+ and 6OHDA toxins and after α-synuclein fibril 
treatment; α-synuclein protein is a major constituent of Lewy bodies in PD neurons and use of 
their fibril in cell culture makes an effective PD model [208].  Furthermore, there is elevated 
Trib3 staining in DA neurons of the SNpc in patients with PD.  Dr. Aime’s data have also 
extended my findings that Trib3 shRNA protects in PD toxin models.  In preliminary studies, Dr. 
Bernd has also found that Trib3 staining is evident in the CA1, frontal cortex and choroid plexus 
of human control and AD brains, suggesting that elevated Trib3 expression may correlate to 
susceptibility to neuron death in AD.  Another collaborating scientist, Dr. Subhas C. Biswas, has 
recently confirmed my findings by showing that shRNA against Trib3 can protect cortical 
neurons from Aβ1-42 toxicity.  Additionally, I have shown in chapter 2 that Trib3 knockdown is 
very effective in protecting neuron morphology and processes even after a week of NGF 
deprivation.  This may have very important implications for neurodegenerative diseases.  In PD, 
for example, axon degeneration precedes death of the soma; and therefore, it is widely 
acknowledged that halting axon degeneration may be a more effective method for preventing 
neuron death [188].  Taken together the data presented in this thesis and the preliminary findings 
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of my collaborators are very encouraging and the role of Trib3 in PD and AD warrants further 
examination.   
As for the mechanism that may be employed by Trib3 in these death paradigms, Akt may 
prove to be a target.  6OHDA toxicity has been shown to result in Akt dephosphorylation in both 
neuronal PC12 cells and SCG neurons [55].  In AD, NGF deprivation is considered to be an 
etiological factor for the sporadic form as researchers have shown that there is increased 
amyloidogenic processing of APP and Tau phosphorylation in the absence of NGF [24].   In cell 
culture models consisting of PC12 cells and Hippocampal and cortical neurons, NGF signaling is 
protective against Aβ1-42 induced neurodegeneration [209].    
Furthermore, attenuated insulin and/or IGF-1 signaling has been linked to development of AD 
pathology in cell-culture models, laboratory animals and AD patients [210-212].   It has been 
shown that insulin resistance and activated GSK3β leads to increased Tau phosphorylation, 
neurofibrillary tangles and Aβ plaque formation.  Because of these effects, AD has also been 
referred to as brain specific type III diabetes [213].  As discussed in chapter 1, GSK3β is a 
substrate of Akt and Akt activity inhibits GSK3β via phosphorylation.  Insulin, IGF-1 and NGF 
signaling all require the canonical signal transduction pathway involving PI3K/Akt; therefore, 
Akt phosphorylation and activation may play an important role in AD pathogenesis.  Research 
has revealed that hippocampal neurons of PS1xAPP transgenic mice display show low levels of 
phosphorylated Akt and GSK3β as disease progresses and is accompanied by elevated levels of 
Bim and Bad [212]. Aβ1-42 in cell-culture can block insulin/IGF-1 receptor mediated activation of 
PI3K/Akt, inhibit NGF stimulation of TrkA signaling and result in GSK3β dephosphorylation 
and activation (Jimenez 2011).  On the other hand, researchers have reported increased levels of 
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phospho-Akt in AD neurons as a result of Aβ1-42 dependent stimulation of insulin and IGF-1 
receptors (O, Neil 2012).  One study revealed that neurofibrillary tangle harboring neurons of 
AD brains also display increased levels of phospho-Akt and phospho-GSK3 β; this is thought be 
a response elicited by neurons in order to reduce GSK3 β activity (Pei 2003).   Thus the 
regulation and consequences of Akt activation appears to be a complex matter in AD models and 
AD brain and it should be investigated whether or not Trib3 plays any role in this. 
Another potential future endeavor would be to examine the transcriptional pathways by which 
Trib3 may be regulated during neurodegeneration.  ATF4 and CHOP are activated following PD 
toxin administration and the apoptotic cell-cycle pathway regulates gene induction in response to 
Aβ toxicity [164, 168, 205].  It can be explored whether Trib3 upregulation in PD is mediated by 
ATF4-CHOP and whether the apoptotic cell-cycle pathways may also contribute to inducing 
Trib3 in AD models.  Since Trib3 appears to play a significant role in in vitro models of 
neurodegenerative diseases, namely PD and AD, understanding how it is regulated 








Final Remarks   
The ongoing search for additional pro-apoptotic genes has led researchers to take notice of the 
serine-threonine-like pseudokinase Trib3.  The protein has a remarkably wide range of functions 
that are cell-type and context specific.  These functions of Trib3 include regulating energy 
metabolism and mediating cell death or promoting survival in non-neuronal cells depending on 
the type of stress.   To this list of activities we can now include its ability to induce neuronal 
apoptosis that is evident during development and in neurodegeneration.  The findings regarding 
Trib3’s role in neuron death have enabled us to gained additional insight into the mechanism of 
developmental apoptosis and have inspired other researchers to launch investigations that will 
contribute to understanding the process of pathological neuron death and may aid in developing 












Materials and Methods 
Cell Culture: PC12 cells were grown as previously described  [214] on plates (Nunclone) coated 
with rat tail collagen (Roche).  Undifferentiated, naïve PC12 cells are maintained in complete 
medium (RPMI 1640 medium (Cellgro) supplemented with 10% heat inactivated horse serum 
and 5% fetal bovine serum (Sigma).  Neuronal differentiation was induced in RPMI medium 
supplemented with 1% horse serum and 100 ɳg/ml hNGF (kind gift of Genentech, Inc).  Rat 
superior cervical ganglionic (SCG) neuron cultures were generated and maintained as previously 
described [215] and can be found in the Appendix.    NGF withdrawal was carried out by 
washing the cultures with serum-free RPMI medium three to four times and then maintaining 
them in serum free RPMI plus 10 µg/ml anti-NGF antibody (R&D System, Cat# MAB2561)  
HEK293T/17 cells were cultured in uncoated polystyrene plates (Corning) with DMEM cell 
culture medium supplemented with 10% fetal bovine serum.  Embryonic cortical neuronal 
cultures were generous gifts from Dr. Jin Liu in the Lloyd Greene laboratory.  They were 
cultured as described previously [216], grown on plates coated with poly-D-Lysine and 
maintained in neurobasal medium. 
Antibodies: Anti-Trib3 antibodies were purchased from Santa Cruz Biotechnology, Inc 
(SC67122 for Western blotting and SC314214 for immunostaining) and EMD Millipore 
(ST1032) and used at either 1:200 for immunostaining or at 1:1000 for immunoblotting.  
Monoclonal antibodies against total AKT, phospho-AKT (Ser473 and Thr308) and total FoxO1a 
and polyclonal antiserum against phospho-FoxO1a (Ser256) were from Cell Signaling 
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Technology and used at 1:1000 for immunoblotting.  A second polyclonal antiserum against total 
FoxO1a was also obtained from AbCam.  Both FoxO1a antibodies were used at 1:200 for 
immunostaining.  Monoclonal antibodies against beta-tubulin III (1:1000 for immunostaining) 
and GFP (1:1000 for immunostaining) were from Sigma-Aldrich and Invitrogen, respectively.   
A monoclonal antibody against phospho-Histone2AX (Cell Signaling #9718) was used at 1:200 
for immunohistochemistry. 
Plasmids:  Primers used for PCR amplification of rat Trib3 were: Fwd 5’ 
ACCATGCGAGCCACATCTCTG 3’ and Rvrs 5’CTAGCCATACAGCCCCACCTC3’.  PCR 
products were gel purified and cloned into PmeI digested vector pWPI 
(AddGene/http://tronolab.epfl.ch).  Primers used for shTrib3 were based on the following Trib3 
sequences: shTrib3#1 5’GAGTGAGAGATGAGCCTG3’, shTrib3#2 
5’CTGGAGGATGCCTGTGTG3’ and shTrib3#3 5’TGCTCGATTTGTCTTCAGCAA3’.  
Forward and reverse oligonucleotides were 5’ phosphorylated, annealed and cloned into Hpa1-
Xho1-digested pLL 3.7 vector [217].  Primers used for pan shFoxO were based on the sequence 
5’GGATAAGGGCGACAGCAA3’ [178].  Primers used for shBim were based on the following 
sequences: shBim#1 5’GACAGAGAAGGTGGACAATTG3’ [168] and shBim#2 
5’TTCGATTACCGAGAGGCGGAA3’. 
Lentiviral Preparation: HEK293T/17 cells (ATCC) were co-transfected with pLL3.7 
containing the desired shRNA construct and third generation lentiviral packaging plasmids, 
RRE, Rsv/Rev and VSV-G (AddGene), using the Ca-phosphate method [218].  For 
overexpression, cells were co-transfected with pWPI plasmid containing the Trib3 cDNA and 
second generation lentiviral packaging plasmids, pSPAX2 and VSV-G (AddGene).  4 hours later 
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medium containing Ca-phosphate was replaced by fresh DMEM supplemented with 10% FBS.  
Lentiviral medium was collected 72 hours later and replaced \with fresh DMEM supplemented 
with 10% FBS.  A second lentiviral medium was collected 24 hours later.  All lentiviral 
supernatants were pooled, filtered through a 0.45 micron membrane (Nalgene) and subjected to 
ultracentrifugation in clear tubes (Beckman Scientific) at 25,000 rpm using Beckman SW28 
rotor in a Beckman Coulter ultracentrifuge for 1.5 hours.  Supernatants were discarded and viral 
pellets were incubated in PBS without MgCl2 or CaCl2 overnight.  The dissolved pellets were 
triturated 20 times, centrifuged briefly to discard any remaining cell debris, aliquoted in small 
volumes and stored at -80ºC.  Viral titration was performed as described [218]. 
Lentiviral Infection:  A predetermined volume (approximate viral MOI between 10 and 15 as 
determined by viral titration) of lentivirus was added to the medium, which was then added to 
cultures of neuronal PC12 cells and SCG neurons.  The medium was exchanged for one without 
virus between 72 hours to 5 days later.  
Transfections: DNA was prepared with a Plasmid Maxi kit (Qiagen or Sigma-Aldrich).  PC12 
cells were transfected with 1 to 2 µg of plasmid in 48-well dishes using LipofectAMINE 2000.  4 
hours later, medium with LipofectAMINE 2000 was supplemented with fresh RPMI medium 
supplemented with 1% horse serum and 100 ɳg/mL NGF.  Transfected GFP or mCherry positive 
cells were visualized under a Nikon TE300 epi-fluorescent microscope.   
Western Immunoblotting:  Neuronal PC12 cells and SCG neurons were lysed with Laemmli 
Sample Buffer supplemented with 2-mercaptoethanol (BioRad), sonicated and subjected to 
electrophoresis using pre-cast Bis-Tris 10% or 4-12% SDS gels (Invitrogen).  Protein was then 
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transferred to HyBond PVDF membrane (GE Amersham Biosciences).  5% non-fat dry milk in 
TBS-Tween20 buffer was used as blocking agent and diluent for secondary antibody against 
total ERK.  5% bovine serum albumin dissolved in TBS-Tween20 buffer was used as diluent for 
primary antibodies.  Detection was carried out using either ECL or ECL+ chemiluminescence 
according to the manufacturer’s instructions (GE Amersham Biosciences).     
Immunostaining:  Neuronal PC12 cells and SCG neurons were cultured in 8-chambered 
borosilicate coverglass devices (Nunc LabTek cat# 155411) and fixed with 4% 
paraformaldehyde for 10 min.  Cells were then washed three times with PBS and blocked in 
SuperBlock buffer (Pierce) in PBS for 2 hours.  The cultures were then incubated with the 
appropriate antibodies or antisera diluted in blocking buffer overnight.  Cultures were washed 
with PBS the next day and this was followed by incubation with the appropriate secondary 
antibody for 2 hours in room temperature.  Finally, cultures were labeled with the nuclear stain 
ToproIII at 1/2000 dilution in PBS (Molecular Probes).  Immunostained cells were visualized 
and photographed using a spinning disk confocal microscope.  
Harvest and immunohistochemistry of mouse superior cervical ganglia: WT and Trib3-/- 
mice pups at ages P3 and P7 were collected and sacrificed.  A disk-shaped section of the neck 
area containing the superior cervical ganglia was obtained from each animal and drop-fixed in 
4% paraformaldehyde for at least 48 hours.  The neck pieces were given to Columbia 
University’s resident histology service.  They embedded the pieces in paraffin and made 5μm 
thick sections.  25 such sections were obtained for each neck pieces, which contained both the 
right and left ganglia.  4 sections were mounted on a single glass slide and every 5th section was 
stained with hematoxylin and eosin by the histology service providers.  The remaining sections 
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were immunostained with antibody against pH2AX protein by me using the following method.  
For immunohistochemistry, the sections were deparafinized by serial incubations for 5 min each 
in 2x100% xylene, 1:1 xylene:ethanol solution, 2x100% ethanol/water solution, 95%, 70% and 
50% ethanol/water solution following by tap water rinse for 10 min.  The sections were then 
submerged in sodium citrate buffer (2.94g tri-sodium citrate dihydrate + 1000mL dH2O+ 0.5 mL 
Tween 20) pH 6.0 and placed in a steamer for 45 minutes for antigen retrieval.  After cooling 
down to room temperature, sections were blocked in blocking reagent provided by the 
Vectastatin Elite ABC Kit (Vector Laboratories) for 20 min and then incubated in primary 
antibody (anti-pH2AX) for overnight at 4ºC.  The next day, sections were washed in a sodium-
phosphate buffer and incubated in biotinylated secondary-antibody from the Vectastatin Elite 
ABC Kit for 30 min.  After a brief rinse in sodium-phosphate buffer, they were incubated in 
ABC-AP reagent (Vector Laboratories) for 30 min.  This was followed by another brief rinse and 
incubation in peroxidase substrate for approximately 5 min.  The sections were counterstained 
with Nuclear Fast Red (Vector Laboratories) for 7 minutes, dehydrated by serial incubation 
going from water to ethanol to xylene and mounted with coverslips.  They were visualized and 
photographed under a microscope.   
Reverse transcription and quantitative PCR:  Cells were lysed and total mRNA was isolated 
using TRI reagent (Molecular Research Center, Cincinnati, OH) following manufacturer’s 
instruction. cDNA was transcribed from total RNA with a cDNA synthesis kit (Marligen) 
following manufacturer’s instruction. The primers used for PCR amplification of rat Trib3 were 
Fwd 5’GTTGCGTCGATTTGTCTTCA3’ and Rvrs: 5’CGGGAGCTGAGTATCTCTGG3’, Bim 
forward 5’GCCCCTACCTCCCTACAGAC3’ and reverse 
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5’CCTTATGGAAGCCATTGCAC3’, GAPDH forward 5’AAGTGGACATTGTTGCCATC3’ 
and reverse 5’CATACTCAGCACCAGCATCA3’ and α-tubulin Fwd 
5’TACACCATTGGCAAGGAGAT3’ and reverse 5’GGCTGGGTAAATGGAGAACT3’.  An 
equal amount of cDNA template was used for each PCR reaction.  An OmniMix PCR kit 
(Cephaid) and a SYBR green/DNA polymerase PCR kit was used (Roche) and quantitative PCR 
reactions were carried out using a Cephaid SmartCycler and an Eppendorf Realplex 
thermocycler following the manufacturers’ specifications.  Values obtained from SYBR green 
count were recorded and transcript levels were normalized against rat GAPDH and alpha-tubulin 
signals and results were reported as times fold increase in reference to control values as 
described previously [219]. 
Neurodegeneration reagents:  6OHDA (Tocris Bioscience) stock solutions were prepared as 
described in [220].  Appropriate volumes were added to the neuronal PC12 cells cultures during 
feeding to obtain the final desirable concentration.  Aβ1-42 dodecamer (R-Peptide, cat#: A-1163-
2) preparations were made as described previously in DMSO [203] and added to culture medium 
during feeding. 
Statistics: The statistical significance of differences between means was evaluated by Student’s t 
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